| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH6 DHX58 SPG7 DYNC2H1 MYH7B SMC4 RNF213 ABCA8 DDX1 DHX30 ABCB4 IQCA1L ABCA6 ABCB11 ABCD1 RFT1 HSPA9 TOP2A TOP2B | 5.24e-09 | 614 | 121 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | DHX58 SPG7 DYNC2H1 SMC4 RNF213 ABCA8 DDX1 DHX30 ABCB4 IQCA1L ABCA6 ABCB11 ABCD1 HSPA9 | 4.71e-07 | 441 | 121 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 1.16e-05 | 49 | 121 | 5 | GO:0140359 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | DHX58 SPG7 DYNC2H1 SMC4 RNF213 ABCA8 GFM2 DDX1 DHX30 ABCB4 IQCA1L NUDT11 ABCA6 NUDT10 ABCB11 ABCD1 HSPA9 | 1.23e-05 | 839 | 121 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | DHX58 SPG7 DYNC2H1 SMC4 RNF213 ABCA8 GFM2 DDX1 DHX30 ABCB4 IQCA1L NUDT11 ABCA6 NUDT10 ABCB11 ABCD1 HSPA9 | 1.25e-05 | 840 | 121 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | DHX58 SPG7 DYNC2H1 SMC4 RNF213 ABCA8 GFM2 DDX1 DHX30 ABCB4 IQCA1L NUDT11 ABCA6 NUDT10 ABCB11 ABCD1 HSPA9 | 1.25e-05 | 840 | 121 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | methionine adenosyltransferase activity | 3.64e-05 | 2 | 121 | 2 | GO:0004478 | |
| GeneOntologyMolecularFunction | bone sialoprotein binding | 3.64e-05 | 2 | 121 | 2 | GO:0044730 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | DHX58 SPG7 DYNC2H1 SMC4 RNF213 ABCA8 GFM2 DDX1 DHX30 ABCB4 IQCA1L ABCA6 ABCB11 ABCD1 HSPA9 | 7.03e-05 | 775 | 121 | 15 | GO:0017111 |
| GeneOntologyMolecularFunction | DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity | 2.17e-04 | 4 | 121 | 2 | GO:0003918 | |
| GeneOntologyMolecularFunction | endopolyphosphatase activity | 3.60e-04 | 5 | 121 | 2 | GO:0000298 | |
| GeneOntologyMolecularFunction | phospholipase A2 inhibitor activity | 3.60e-04 | 5 | 121 | 2 | GO:0019834 | |
| GeneOntologyMolecularFunction | bis(5'-adenosyl)-hexaphosphatase activity | 3.60e-04 | 5 | 121 | 2 | GO:0034431 | |
| GeneOntologyMolecularFunction | diphosphoinositol-polyphosphate diphosphatase activity | 3.60e-04 | 5 | 121 | 2 | GO:0008486 | |
| GeneOntologyMolecularFunction | ATPase-coupled transmembrane transporter activity | 5.32e-04 | 109 | 121 | 5 | GO:0042626 | |
| GeneOntologyMolecularFunction | bis(5'-adenosyl)-pentaphosphatase activity | 5.38e-04 | 6 | 121 | 2 | GO:0034432 | |
| GeneOntologyMolecularFunction | chromatin binding | POLE GATA2 SMC4 NSD1 MEIS1 DDX1 HIRA DHX30 PARP1 RBMX SUPT16H TOP2A TOP2B | 5.47e-04 | 739 | 121 | 13 | GO:0003682 |
| GeneOntologyMolecularFunction | single-stranded RNA binding | 5.78e-04 | 111 | 121 | 5 | GO:0003727 | |
| GeneOntologyMolecularFunction | DNA topoisomerase activity | 9.96e-04 | 8 | 121 | 2 | GO:0003916 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.10e-03 | 262 | 121 | 7 | GO:0140097 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.25e-03 | 196 | 121 | 6 | GO:0005319 | |
| GeneOntologyMolecularFunction | ATPase-coupled lipid transmembrane transporter activity | 1.28e-03 | 9 | 121 | 2 | GO:0034040 | |
| GeneOntologyBiologicalProcess | tetrahydrofolate metabolic process | 9.15e-06 | 23 | 121 | 4 | GO:0046653 | |
| GeneOntologyBiologicalProcess | multi-pass transmembrane protein insertion into ER membrane | 1.61e-05 | 9 | 121 | 3 | GO:0160063 | |
| GeneOntologyBiologicalProcess | alpha-amino acid metabolic process | 1.75e-05 | 251 | 121 | 9 | GO:1901605 | |
| GeneOntologyBiologicalProcess | cardiac muscle hypertrophy | 2.08e-05 | 142 | 121 | 7 | GO:0003300 | |
| GeneOntologyBiologicalProcess | striated muscle hypertrophy | 2.48e-05 | 146 | 121 | 7 | GO:0014897 | |
| GeneOntologyBiologicalProcess | amino acid metabolic process | MAT1A GART ALDH8A1 NOX4 UROC1 MCCC1 WARS2 SLC39A8 MTHFD1 MTR | 2.66e-05 | 332 | 121 | 10 | GO:0006520 |
| GeneOntologyBiologicalProcess | muscle hypertrophy | 2.71e-05 | 148 | 121 | 7 | GO:0014896 | |
| GeneOntologyBiologicalProcess | circulatory system development | NDNF MYH6 DYNC2H1 ANXA2 WNT2 ANXA2P2 RBM10 GATA2 RNF213 NOX4 C1GALT1 TEK WARS2 MEIS1 TGM2 LMNA TIE1 MTHFD1 VWA5A LOXL1 AKAP13 MMP14 | 3.07e-05 | 1442 | 121 | 22 | GO:0072359 |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein particle receptor binding | 3.41e-05 | 2 | 121 | 2 | GO:1905597 | |
| GeneOntologyBiologicalProcess | protein deamination | 3.41e-05 | 2 | 121 | 2 | GO:0018277 | |
| GeneOntologyBiologicalProcess | positive regulation of single stranded viral RNA replication via double stranded DNA intermediate | 3.41e-05 | 2 | 121 | 2 | GO:0045870 | |
| GeneOntologyBiologicalProcess | endomembrane system organization | DYNC2H1 ANXA2 ANXA2P2 IST1 ALS2 NOMO1 LMNA TIE1 NOMO2 REEP6 FER1L4 ABCD1 CAMSAP2 NOMO3 | 4.04e-05 | 672 | 121 | 14 | GO:0010256 |
| GeneOntologyBiologicalProcess | folic acid-containing compound metabolic process | 4.56e-05 | 34 | 121 | 4 | GO:0006760 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell differentiation | 8.45e-05 | 177 | 121 | 7 | GO:0055007 | |
| GeneOntologyBiologicalProcess | homocysteine metabolic process | 8.51e-05 | 15 | 121 | 3 | GO:0050667 | |
| GeneOntologyBiologicalProcess | sulfur amino acid metabolic process | 8.75e-05 | 40 | 121 | 4 | GO:0000096 | |
| GeneOntologyBiologicalProcess | pteridine-containing compound metabolic process | 8.75e-05 | 40 | 121 | 4 | GO:0042558 | |
| GeneOntologyBiologicalProcess | positive regulation of sterol transport | 8.75e-05 | 40 | 121 | 4 | GO:0032373 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol transport | 8.75e-05 | 40 | 121 | 4 | GO:0032376 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor-mediated endocytosis involved in cholesterol transport | 1.02e-04 | 3 | 121 | 2 | GO:1905602 | |
| GeneOntologyBiologicalProcess | negative regulation of low-density lipoprotein particle receptor catabolic process | 1.02e-04 | 3 | 121 | 2 | GO:0032804 | |
| GeneOntologyBiologicalProcess | methionine metabolic process | 1.04e-04 | 16 | 121 | 3 | GO:0006555 | |
| GeneOntologyBiologicalProcess | one-carbon metabolic process | 1.28e-04 | 44 | 121 | 4 | GO:0006730 | |
| GeneOntologyBiologicalProcess | calcium import into the mitochondrion | 1.51e-04 | 18 | 121 | 3 | GO:0036444 | |
| GeneOntologyBiologicalProcess | xenobiotic transmembrane transport | 1.78e-04 | 19 | 121 | 3 | GO:0006855 | |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein particle clearance | 2.03e-04 | 4 | 121 | 2 | GO:1905581 | |
| GeneOntologyBiologicalProcess | negative regulation of receptor catabolic process | 2.03e-04 | 4 | 121 | 2 | GO:2000645 | |
| GeneOntologyBiologicalProcess | S-adenosylmethionine biosynthetic process | 2.03e-04 | 4 | 121 | 2 | GO:0006556 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular cholesterol transport | 2.03e-04 | 4 | 121 | 2 | GO:0032385 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular sterol transport | 2.03e-04 | 4 | 121 | 2 | GO:0032382 | |
| GeneOntologyBiologicalProcess | L-amino acid metabolic process | 2.29e-04 | 208 | 121 | 7 | GO:0170033 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | MYH6 RBM10 NTN3 LAMC1 NOX4 MEIS1 HIRA LMNA VWA5A AKAP13 MMP14 | 2.96e-04 | 531 | 121 | 11 | GO:0042692 |
| GeneOntologyBiologicalProcess | cardiocyte differentiation | 3.31e-04 | 221 | 121 | 7 | GO:0035051 | |
| GeneOntologyBiologicalProcess | nuclear pore localization | 3.37e-04 | 5 | 121 | 2 | GO:0051664 | |
| GeneOntologyBiologicalProcess | positive regulation of plasma membrane repair | 3.37e-04 | 5 | 121 | 2 | GO:1905686 | |
| GeneOntologyBiologicalProcess | regulation of low-density lipoprotein particle receptor binding | 3.37e-04 | 5 | 121 | 2 | GO:1905595 | |
| GeneOntologyBiologicalProcess | adenosine 5'-(hexahydrogen pentaphosphate) metabolic process | 3.37e-04 | 5 | 121 | 2 | GO:1901910 | |
| GeneOntologyBiologicalProcess | adenosine 5'-(hexahydrogen pentaphosphate) catabolic process | 3.37e-04 | 5 | 121 | 2 | GO:1901911 | |
| GeneOntologyBiologicalProcess | diadenosine pentaphosphate catabolic process | 3.37e-04 | 5 | 121 | 2 | GO:1901907 | |
| GeneOntologyBiologicalProcess | diadenosine pentaphosphate metabolic process | 3.37e-04 | 5 | 121 | 2 | GO:1901906 | |
| GeneOntologyBiologicalProcess | diadenosine hexaphosphate catabolic process | 3.37e-04 | 5 | 121 | 2 | GO:1901909 | |
| GeneOntologyBiologicalProcess | diadenosine hexaphosphate metabolic process | 3.37e-04 | 5 | 121 | 2 | GO:1901908 | |
| GeneOntologyBiologicalProcess | diphosphoinositol polyphosphate metabolic process | 3.37e-04 | 5 | 121 | 2 | GO:0071543 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular lipid transport | 3.37e-04 | 5 | 121 | 2 | GO:0032379 | |
| GeneOntologyBiologicalProcess | blood vessel development | NDNF DYNC2H1 ANXA2 WNT2 ANXA2P2 GATA2 RNF213 C1GALT1 TEK WARS2 MEIS1 TGM2 TIE1 LOXL1 MMP14 | 3.56e-04 | 929 | 121 | 15 | GO:0001568 |
| GeneOntologyBiologicalProcess | mitochondrial calcium ion transmembrane transport | 4.12e-04 | 25 | 121 | 3 | GO:0006851 | |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | 5.04e-04 | 391 | 121 | 9 | GO:0051146 | |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein receptor activity | 5.04e-04 | 6 | 121 | 2 | GO:1905599 | |
| GeneOntologyBiologicalProcess | diadenosine polyphosphate catabolic process | 5.04e-04 | 6 | 121 | 2 | GO:0015961 | |
| GeneOntologyBiologicalProcess | 10-formyltetrahydrofolate metabolic process | 5.04e-04 | 6 | 121 | 2 | GO:0009256 | |
| GeneOntologyBiologicalProcess | negative regulation of adipose tissue development | 5.04e-04 | 6 | 121 | 2 | GO:1904178 | |
| GeneOntologyBiologicalProcess | muscle structure development | MYH6 WNT2 RBM10 NTN3 LAMC1 NOX4 MEIS1 HIRA FXR1 SNW1 LMNA VWA5A AKAP13 MMP14 | 5.09e-04 | 858 | 121 | 14 | GO:0061061 |
| GeneOntologyBiologicalProcess | definitive hemopoiesis | 5.20e-04 | 27 | 121 | 3 | GO:0060216 | |
| GeneOntologyBiologicalProcess | vasculature development | NDNF DYNC2H1 ANXA2 WNT2 ANXA2P2 GATA2 RNF213 C1GALT1 TEK WARS2 MEIS1 TGM2 TIE1 LOXL1 MMP14 | 5.52e-04 | 969 | 121 | 15 | GO:0001944 |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | 6.99e-04 | 327 | 121 | 8 | GO:0048738 | |
| GeneOntologyBiologicalProcess | negative regulation of nodal signaling pathway | 7.03e-04 | 7 | 121 | 2 | GO:1900108 | |
| GeneOntologyBiologicalProcess | regulation of low-density lipoprotein particle receptor catabolic process | 7.03e-04 | 7 | 121 | 2 | GO:0032803 | |
| GeneOntologyBiologicalProcess | low-density lipoprotein particle receptor catabolic process | 7.03e-04 | 7 | 121 | 2 | GO:0032802 | |
| GeneOntologyBiologicalProcess | low-density lipoprotein receptor particle metabolic process | 7.03e-04 | 7 | 121 | 2 | GO:0032799 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell development | 7.67e-04 | 122 | 121 | 5 | GO:0055013 | |
| GeneOntologyBiologicalProcess | protein insertion into ER membrane | 7.85e-04 | 31 | 121 | 3 | GO:0045048 | |
| GeneOntologyBiologicalProcess | proteinogenic amino acid metabolic process | 7.86e-04 | 185 | 121 | 6 | GO:0170039 | |
| GeneOntologyBiologicalProcess | regulation of receptor-mediated endocytosis involved in cholesterol transport | 9.34e-04 | 8 | 121 | 2 | GO:1905600 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane repair | 9.34e-04 | 8 | 121 | 2 | GO:1905684 | |
| GeneOntologyBiologicalProcess | tetrahydrofolate biosynthetic process | 9.34e-04 | 8 | 121 | 2 | GO:0046654 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor binding | 9.34e-04 | 8 | 121 | 2 | GO:1900122 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle tissue morphogenesis | 9.34e-04 | 8 | 121 | 2 | GO:0055009 | |
| GeneOntologyBiologicalProcess | angiogenesis | NDNF ANXA2 ANXA2P2 GATA2 RNF213 C1GALT1 TEK WARS2 MEIS1 TGM2 TIE1 MMP14 | 9.38e-04 | 708 | 121 | 12 | GO:0001525 |
| GeneOntologyBiologicalProcess | membrane organization | SPG7 ANXA2 ANXA2P2 GATA2 NOMO1 ABCB4 LMNA TIE1 NOMO2 FER1L4 ABCD1 RFT1 HSPA9 NOMO3 | 9.43e-04 | 914 | 121 | 14 | GO:0061024 |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 1.06e-03 | 349 | 121 | 8 | GO:0014706 | |
| GeneOntologyBiologicalProcess | cardiac cell development | 1.09e-03 | 132 | 121 | 5 | GO:0055006 | |
| GeneOntologyBiologicalProcess | organic acid catabolic process | 1.13e-03 | 272 | 121 | 7 | GO:0016054 | |
| GeneOntologyBiologicalProcess | carboxylic acid catabolic process | 1.13e-03 | 272 | 121 | 7 | GO:0046395 | |
| GeneOntologyBiologicalProcess | diadenosine polyphosphate metabolic process | 1.20e-03 | 9 | 121 | 2 | GO:0015959 | |
| GeneOntologyBiologicalProcess | regulation of nodal signaling pathway | 1.20e-03 | 9 | 121 | 2 | GO:1900107 | |
| GeneOntologyBiologicalProcess | L-amino acid catabolic process | 1.26e-03 | 80 | 121 | 4 | GO:0170035 | |
| GeneOntologyCellularComponent | multi-pass translocon complex | 1.51e-05 | 9 | 120 | 3 | GO:0160064 | |
| GeneOntologyCellularComponent | pinosome | 2.94e-05 | 11 | 120 | 3 | GO:0044352 | |
| GeneOntologyCellularComponent | macropinosome | 2.94e-05 | 11 | 120 | 3 | GO:0044354 | |
| GeneOntologyCellularComponent | ER membrane insertion complex | 6.41e-05 | 14 | 120 | 3 | GO:0072379 | |
| GeneOntologyCellularComponent | AnxA2-p11 complex | 9.77e-05 | 3 | 120 | 2 | GO:1990665 | |
| GeneOntologyCellularComponent | methionine adenosyltransferase complex | 9.77e-05 | 3 | 120 | 2 | GO:0048269 | |
| GeneOntologyCellularComponent | PCSK9-AnxA2 complex | 9.77e-05 | 3 | 120 | 2 | GO:1990667 | |
| GeneOntologyCellularComponent | contractile actin filament bundle | 3.82e-04 | 107 | 120 | 5 | GO:0097517 | |
| GeneOntologyCellularComponent | stress fiber | 3.82e-04 | 107 | 120 | 5 | GO:0001725 | |
| GeneOntologyCellularComponent | extracellular matrix | NDNF ANXA2 WNT2 ANXA2P2 NTN3 LAMC1 TGM2 FCN1 VWA5A LOXL1 MMP14 KNG1 | 3.96e-04 | 656 | 120 | 12 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | NDNF ANXA2 WNT2 ANXA2P2 NTN3 LAMC1 TGM2 FCN1 VWA5A LOXL1 MMP14 KNG1 | 4.07e-04 | 658 | 120 | 12 | GO:0030312 |
| GeneOntologyCellularComponent | actomyosin | 5.76e-04 | 117 | 120 | 5 | GO:0042641 | |
| GeneOntologyCellularComponent | actin filament bundle | 5.98e-04 | 118 | 120 | 5 | GO:0032432 | |
| GeneOntologyCellularComponent | myelin sheath adaxonal region | 6.73e-04 | 7 | 120 | 2 | GO:0035749 | |
| GeneOntologyCellularComponent | basement membrane | 6.96e-04 | 122 | 120 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | focal adhesion | 8.62e-04 | 431 | 120 | 9 | GO:0005925 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 9.69e-04 | 530 | 120 | 10 | GO:0062023 | |
| GeneOntologyCellularComponent | cell-substrate junction | 1.05e-03 | 443 | 120 | 9 | GO:0030055 | |
| GeneOntologyCellularComponent | intercellular canaliculus | 1.15e-03 | 9 | 120 | 2 | GO:0046581 | |
| GeneOntologyCellularComponent | ruffle | 1.23e-03 | 206 | 120 | 6 | GO:0001726 | |
| GeneOntologyCellularComponent | nuclear matrix | 1.29e-03 | 140 | 120 | 5 | GO:0016363 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 1.80e-03 | 576 | 120 | 10 | GO:0015629 | |
| GeneOntologyCellularComponent | azurophil granule lumen | 1.88e-03 | 91 | 120 | 4 | GO:0035578 | |
| GeneOntologyCellularComponent | secretory granule lumen | 2.74e-03 | 325 | 120 | 7 | GO:0034774 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle lumen | 2.98e-03 | 330 | 120 | 7 | GO:0060205 | |
| GeneOntologyCellularComponent | vesicle lumen | 3.08e-03 | 332 | 120 | 7 | GO:0031983 | |
| GeneOntologyCellularComponent | nuclear periphery | 3.09e-03 | 171 | 120 | 5 | GO:0034399 | |
| Domain | DUF2012 | 9.79e-07 | 4 | 118 | 3 | PF09430 | |
| Domain | DUF2012 | 9.79e-07 | 4 | 118 | 3 | IPR019008 | |
| Domain | AAA | 3.68e-06 | 144 | 118 | 8 | SM00382 | |
| Domain | AAA+_ATPase | 3.68e-06 | 144 | 118 | 8 | IPR003593 | |
| Domain | ABC_tran | 1.27e-05 | 48 | 118 | 5 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 1.27e-05 | 48 | 118 | 5 | PS50893 | |
| Domain | Carb-bd-like_fold | 1.35e-05 | 8 | 118 | 3 | IPR013784 | |
| Domain | ABC_TRANSPORTER_1 | 1.41e-05 | 49 | 118 | 5 | PS00211 | |
| Domain | ABC_transporter-like | 1.56e-05 | 50 | 118 | 5 | IPR003439 | |
| Domain | P-loop_NTPase | MYH6 DHX58 SPG7 DYNC2H1 MYH7B SMC4 RNF213 ABCA8 GFM2 DDX1 DHX30 ABCB4 ABCA6 MTHFD1 ABCB11 ABCD1 CAMTA1 | 2.37e-05 | 848 | 118 | 17 | IPR027417 |
| Domain | - | 3.96e-05 | 2 | 118 | 2 | 3.40.50.670 | |
| Domain | DTHCT | 3.96e-05 | 2 | 118 | 2 | IPR012542 | |
| Domain | DNA_gyraseB | 3.96e-05 | 2 | 118 | 2 | PF00204 | |
| Domain | S-AdoMet_synt_N | 3.96e-05 | 2 | 118 | 2 | PF00438 | |
| Domain | - | 3.96e-05 | 2 | 118 | 2 | 3.90.199.10 | |
| Domain | TopoIIA_CS | 3.96e-05 | 2 | 118 | 2 | IPR018522 | |
| Domain | S-AdoMet_synthetase | 3.96e-05 | 2 | 118 | 2 | IPR002133 | |
| Domain | Topo_IIA | 3.96e-05 | 2 | 118 | 2 | IPR001241 | |
| Domain | DNA_topoisoIV | 3.96e-05 | 2 | 118 | 2 | PF00521 | |
| Domain | Topo_IIA_A/C_ab | 3.96e-05 | 2 | 118 | 2 | IPR013758 | |
| Domain | Topo_IIA_A_a | 3.96e-05 | 2 | 118 | 2 | IPR013757 | |
| Domain | Topo_IIA_cen_dom | 3.96e-05 | 2 | 118 | 2 | IPR013759 | |
| Domain | TOP4c | 3.96e-05 | 2 | 118 | 2 | SM00434 | |
| Domain | TOP2c | 3.96e-05 | 2 | 118 | 2 | SM00433 | |
| Domain | Topo_IIA-like_dom | 3.96e-05 | 2 | 118 | 2 | IPR013760 | |
| Domain | Topo_IIA_bsu_dom2 | 3.96e-05 | 2 | 118 | 2 | IPR013506 | |
| Domain | DTHCT | 3.96e-05 | 2 | 118 | 2 | PF08070 | |
| Domain | S-AdoMet_synt_M | 3.96e-05 | 2 | 118 | 2 | PF02772 | |
| Domain | S-AdoMet_synt_C | 3.96e-05 | 2 | 118 | 2 | PF02773 | |
| Domain | ADOMET_SYNTHASE_CS | 3.96e-05 | 2 | 118 | 2 | IPR022631 | |
| Domain | S-AdoMet_synt_C | 3.96e-05 | 2 | 118 | 2 | IPR022630 | |
| Domain | - | 3.96e-05 | 2 | 118 | 2 | 1.10.268.10 | |
| Domain | S-AdoMet_synthetase_sfam | 3.96e-05 | 2 | 118 | 2 | IPR022636 | |
| Domain | S-AdoMet_synt_central | 3.96e-05 | 2 | 118 | 2 | IPR022629 | |
| Domain | S-AdoMet_synt_N | 3.96e-05 | 2 | 118 | 2 | IPR022628 | |
| Domain | TOPRIM_C | 3.96e-05 | 2 | 118 | 2 | IPR031660 | |
| Domain | TOPRIM_C | 3.96e-05 | 2 | 118 | 2 | PF16898 | |
| Domain | ADOMET_SYNTHASE_1 | 3.96e-05 | 2 | 118 | 2 | PS00376 | |
| Domain | ADOMET_SYNTHASE_2 | 3.96e-05 | 2 | 118 | 2 | PS00377 | |
| Domain | Topo_IIA_A/C | 3.96e-05 | 2 | 118 | 2 | IPR002205 | |
| Domain | TOPOISOMERASE_II | 3.96e-05 | 2 | 118 | 2 | PS00177 | |
| Domain | CarboxyPept_regulatory_dom | 6.71e-05 | 13 | 118 | 3 | IPR014766 | |
| Domain | - | 6.71e-05 | 13 | 118 | 3 | 2.60.40.1120 | |
| Domain | Arg_repress_C-like | 1.18e-04 | 3 | 118 | 2 | IPR024946 | |
| Domain | GART_AS | 1.18e-04 | 3 | 118 | 2 | IPR001555 | |
| Domain | - | 1.18e-04 | 3 | 118 | 2 | 3.30.1360.40 | |
| Domain | GART | 1.18e-04 | 3 | 118 | 2 | PS00373 | |
| Domain | Ald_DH_CS_GLU | 1.30e-04 | 16 | 118 | 3 | IPR029510 | |
| Domain | CarboxyPept-like_regulatory | 1.57e-04 | 17 | 118 | 3 | IPR008969 | |
| Domain | Ald_DH_CS_CYS | 1.57e-04 | 17 | 118 | 3 | IPR016160 | |
| Domain | ALDEHYDE_DEHYDR_CYS | 1.87e-04 | 18 | 118 | 3 | PS00070 | |
| Domain | ALDEHYDE_DEHYDR_GLU | 1.87e-04 | 18 | 118 | 3 | PS00687 | |
| Domain | - | 2.21e-04 | 19 | 118 | 3 | 3.40.605.10 | |
| Domain | Aldedh | 2.21e-04 | 19 | 118 | 3 | PF00171 | |
| Domain | Ald_DH_C | 2.21e-04 | 19 | 118 | 3 | IPR016163 | |
| Domain | Ald_DH_N | 2.21e-04 | 19 | 118 | 3 | IPR016162 | |
| Domain | Ald_DH/histidinol_DH | 2.21e-04 | 19 | 118 | 3 | IPR016161 | |
| Domain | Aldehyde_DH_dom | 2.21e-04 | 19 | 118 | 3 | IPR015590 | |
| Domain | - | 2.21e-04 | 19 | 118 | 3 | 3.40.309.10 | |
| Domain | Toprim | 2.36e-04 | 4 | 118 | 2 | PF01751 | |
| Domain | DNA_pol_B | 2.36e-04 | 4 | 118 | 2 | PF00136 | |
| Domain | - | 2.36e-04 | 4 | 118 | 2 | 3.40.50.170 | |
| Domain | Formyl_transf_N | 2.36e-04 | 4 | 118 | 2 | IPR002376 | |
| Domain | Toprim_domain | 2.36e-04 | 4 | 118 | 2 | IPR006171 | |
| Domain | DNA-dir_DNA_pol_B | 2.36e-04 | 4 | 118 | 2 | IPR006172 | |
| Domain | Formyl_trans_N | 2.36e-04 | 4 | 118 | 2 | PF00551 | |
| Domain | DNA-dir_DNA_pol_B_exonuc | 2.36e-04 | 4 | 118 | 2 | IPR006133 | |
| Domain | DNA-dir_DNA_pol_B_multi_dom | 2.36e-04 | 4 | 118 | 2 | IPR006134 | |
| Domain | DNA_pol_B_exo1 | 2.36e-04 | 4 | 118 | 2 | PF03104 | |
| Domain | TOPRIM | 2.36e-04 | 4 | 118 | 2 | PS50880 | |
| Domain | POLBc | 2.36e-04 | 4 | 118 | 2 | SM00486 | |
| Domain | - | 2.59e-04 | 20 | 118 | 3 | 3.30.565.10 | |
| Domain | - | DHX58 SPG7 DYNC2H1 SMC4 RNF213 ABCA8 GFM2 DDX1 DHX30 ABCB4 ABCA6 MTHFD1 ABCB11 ABCD1 | 2.60e-04 | 746 | 118 | 14 | 3.40.50.300 |
| Domain | - | 3.01e-04 | 21 | 118 | 3 | 3.30.230.10 | |
| Domain | HATPase_C | 3.01e-04 | 21 | 118 | 3 | IPR003594 | |
| Domain | Ribosomal_S5_D2-typ_fold_subgr | 3.47e-04 | 22 | 118 | 3 | IPR014721 | |
| Domain | Rudment_hybrid_motif | 5.84e-04 | 6 | 118 | 2 | IPR011054 | |
| Domain | ABC_TM1F | 7.18e-04 | 28 | 118 | 3 | PS50929 | |
| Domain | ABC1_TM_dom | 7.18e-04 | 28 | 118 | 3 | IPR011527 | |
| Domain | - | 8.14e-04 | 7 | 118 | 2 | 3.30.70.240 | |
| Domain | EFG_V | 8.14e-04 | 7 | 118 | 2 | IPR000640 | |
| Domain | Ribosomal_S5_D2-typ_fold | 1.28e-03 | 34 | 118 | 3 | IPR020568 | |
| Domain | - | 1.38e-03 | 9 | 118 | 2 | 3.30.450.40 | |
| Domain | GAF_dom-like | 1.38e-03 | 9 | 118 | 2 | IPR029016 | |
| Domain | ABC_transporter_CS | 2.36e-03 | 42 | 118 | 3 | IPR017871 | |
| Domain | ABC_A | 2.51e-03 | 12 | 118 | 2 | IPR026082 | |
| Domain | NUDIX_hydrolase_CS | 2.51e-03 | 12 | 118 | 2 | IPR020084 | |
| Domain | - | 2.95e-03 | 13 | 118 | 2 | 3.40.50.20 | |
| Domain | - | NDNF TEK BTN3A2 BTN3A1 NOMO1 TGM2 BTN3A3 TIE1 NOMO2 CAMTA1 NOMO3 | 3.19e-03 | 663 | 118 | 11 | 2.60.40.10 |
| Domain | - | 3.26e-03 | 47 | 118 | 3 | 3.30.420.10 | |
| Domain | ATP_GRASP | 3.43e-03 | 14 | 118 | 2 | PS50975 | |
| Domain | ATP-grasp | 3.43e-03 | 14 | 118 | 2 | IPR011761 | |
| Domain | PreATP-grasp_dom | 3.43e-03 | 14 | 118 | 2 | IPR016185 | |
| Domain | Myosin_N | 3.94e-03 | 15 | 118 | 2 | PF02736 | |
| Domain | Myosin_N | 3.94e-03 | 15 | 118 | 2 | IPR004009 | |
| Domain | - | 3.94e-03 | 15 | 118 | 2 | 3.30.1490.20 | |
| Domain | Laminin_N | 4.48e-03 | 16 | 118 | 2 | IPR008211 | |
| Domain | LamNT | 4.48e-03 | 16 | 118 | 2 | SM00136 | |
| Domain | LAMININ_NTER | 4.48e-03 | 16 | 118 | 2 | PS51117 | |
| Domain | Laminin_N | 4.48e-03 | 16 | 118 | 2 | PF00055 | |
| Pathway | WP_ONECARBON_METABOLISM | 1.45e-06 | 29 | 97 | 5 | M39471 | |
| Pathway | WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT | 7.54e-06 | 19 | 97 | 4 | M39777 | |
| Pathway | KEGG_ABC_TRANSPORTERS | 1.22e-05 | 44 | 97 | 5 | M11911 | |
| Pathway | WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY | 1.40e-05 | 22 | 97 | 4 | M39367 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 6.08e-05 | 99 | 97 | 6 | MM14986 | |
| Pathway | REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS | 6.64e-05 | 12 | 97 | 3 | M27738 | |
| Pathway | WP_SPINA_BIFIDA | 6.64e-05 | 12 | 97 | 3 | M48321 | |
| Pathway | REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT | 7.59e-05 | 103 | 97 | 6 | M758 | |
| Pathway | WP_ONECARBON_METABOLISM | 8.34e-05 | 34 | 97 | 4 | MM15859 | |
| Pathway | WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS | 9.58e-05 | 67 | 97 | 5 | M39710 | |
| Pathway | REACTOME_METHYLATION | 1.09e-04 | 14 | 97 | 3 | M26967 | |
| Pathway | REACTOME_METHYLATION | 1.09e-04 | 14 | 97 | 3 | MM14596 | |
| Pathway | REACTOME_ABC_TRANSPORTER_DISORDERS | 1.97e-04 | 78 | 97 | 5 | M27473 | |
| Pathway | KEGG_ONE_CARBON_POOL_BY_FOLATE | 2.00e-04 | 17 | 97 | 3 | M12039 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 4.42e-04 | 22 | 97 | 3 | MM1370 | |
| Pathway | WP_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS | 5.12e-04 | 54 | 97 | 4 | MM15848 | |
| Pathway | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY | 6.51e-04 | 25 | 97 | 3 | M541 | |
| Pathway | BIOCARTA_MRP_PATHWAY | 6.90e-04 | 6 | 97 | 2 | M22078 | |
| Pathway | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY | 7.32e-04 | 26 | 97 | 3 | MM14481 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | GRIPAP1 ANXA2 MAT2A GART SMC4 IST1 RNF213 LAMC1 PSME1 MCCC1 TWF1 ARHGAP1 TGM2 PARP1 FXR1 SPATS2L SNW1 RBMX FEN1 SUPT16H NUDT10 CTTN EIF3M HSPA9 TOP2A CNN3 | 1.21e-12 | 1367 | 121 | 26 | 32687490 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | ANXA2 MAT2A GART SMC4 HEATR1 ZFC3H1 DDX1 DHX30 TWF1 ARHGAP1 TGM2 PARP1 FXR1 SPATS2L SNW1 LMNA MTHFD1 RBMX FEN1 SUPT16H CTTN UHRF2 EIF3M HSPA9 TOP2A | 1.34e-12 | 1257 | 121 | 25 | 36526897 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DYNC2H1 ANXA2 MAT2A POLE GART SMC4 HEATR1 DDX1 DHX30 NOMO1 PARP1 URB1 FXR1 SNW1 LMNA MTHFD1 RBMX FEN1 SUPT16H MTR ALDH2 CTTN EIF3M HSPA9 TOP2A TOP2B | 3.08e-12 | 1425 | 121 | 26 | 30948266 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MAT2A POLE GART SMC4 HEATR1 MCCC1 DDX1 HIRA DHX30 TGM2 PARP1 URB1 FXR1 SNW1 LMNA MTHFD1 RBMX FEN1 SUPT16H AKAP13 MMP14 EIF3M HSPA9 TOP2A TOP2B | 6.60e-12 | 1353 | 121 | 25 | 29467282 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | DNAJB12 PRPSAP2 ANXA2 MAT2A GART SPC25 SMC4 PSME1 WARS2 DDX1 DHX30 PARP1 FXR1 SNW1 LMNA MTHFD1 RBMX FEN1 SUPT16H AKAP13 CTTN EIF3M HSPA9 TOP2A TOP2B | 1.72e-11 | 1415 | 121 | 25 | 28515276 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ANXA2 RBM10 GART SMC4 LAMC1 HEATR1 DDX1 DHX30 PARP1 URB1 FXR1 SNW1 LMNA SACS MTHFD1 RBMX SUPT16H CTTN HSPA9 TOP2A TOP2B | 6.03e-11 | 1024 | 121 | 21 | 24711643 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | ANXA2 MAT2A RBM10 HEATR1 DDX1 DHX30 PARP1 FXR1 SNW1 LMNA MTHFD1 RBMX FEN1 SUPT16H CTTN HSPA9 TOP2A TOP2B | 6.05e-11 | 714 | 121 | 18 | 28302793 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | STRN3 RBM10 GART IST1 HEATR1 MCCC1 DHX30 TWF1 LENG8 PARP1 SNW1 R3HCC1L MTHFD1 FEN1 CTTN CAMSAP2 HSPA9 TOP2A CNN3 TOP2B | 8.54e-11 | 934 | 121 | 20 | 33916271 |
| Pubmed | PRPSAP2 ANXA2 RBM10 GART SMC4 DDX1 DHX30 TWF1 PARP1 FXR1 SNW1 LMNA MTHFD1 RBMX CTTN HSPA9 | 9.83e-11 | 551 | 121 | 16 | 34728620 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | ANXA2 MAT1A ANXA2P2 MAT2A GART SMC4 HEATR1 DDX1 DHX30 TWF1 PARP1 FXR1 LMNA MTHFD1 RBMX FEN1 SUPT16H CTTN HSPA9 TOP2A | 1.13e-10 | 949 | 121 | 20 | 36574265 |
| Pubmed | DNAJB12 DHX58 PSMB7 SMC4 RNF213 LAMC1 HEATR1 PIGG PSME1 MCCC1 GFM2 DDX1 HIRA TWF1 PARP1 URB1 LMNA SUPT16H ALDH2 CTTN EIF3M TOP2A TOP2B FBXW11 | 1.53e-10 | 1440 | 121 | 24 | 30833792 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | ANXA2 RBM10 HEATR1 MCCC1 DDX1 DHX30 LENG8 PARP1 URB1 SPATS2L SNW1 LMNA MTHFD1 RBMX SUPT16H EIF3M HSPA9 TOP2A CNN3 TOP2B | 2.32e-10 | 989 | 121 | 20 | 36424410 |
| Pubmed | DNAJB12 MAT2A GART SMC4 HEATR1 DDX1 DHX30 NOMO1 PARP1 FXR1 LMNA MTHFD1 RBMX SUPT16H HSPA9 TOP2B | 8.24e-10 | 638 | 121 | 16 | 33239621 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | DNAJB12 ANXA2 ANXA2P2 GART RNF213 LAMC1 C1GALT1 MCCC1 GFM2 DDX1 NOMO1 TGM2 LMNA NOMO2 REEP6 VWA5A ALDH1L2 LOXL1 SUPT16H ALDH2 CTTN HSPA9 NOMO3 | 1.03e-09 | 1451 | 121 | 23 | 30550785 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PRPSAP2 STRN3 GRIPAP1 ANXA2 MAT2A GART SPC25 TBC1D2 PSMB7 SMC4 IST1 PSME1 DDX1 TWF1 TGM2 LMNA MTHFD1 FEN1 SUPT16H MTR CTTN EIF3M HSPA9 | 1.08e-09 | 1455 | 121 | 23 | 22863883 |
| Pubmed | RBM10 GART IST1 HEATR1 DDX1 DHX30 TWF1 TGM2 PARP1 FXR1 LMNA RBMX SUPT16H CTTN TOP2A TOP2B | 1.34e-09 | 660 | 121 | 16 | 32780723 | |
| Pubmed | DNAJB12 DYNC2H1 POLE LAMC1 RTN4IP1 HEATR1 ZFC3H1 DHX30 NOMO1 ARHGAP1 PARP1 URB1 SNW1 R3HCC1L LMNA SACS NOMO2 SUPT16H MTR AKAP13 ALDH2 HSPA9 TOP2B | 1.64e-09 | 1487 | 121 | 23 | 33957083 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | DNAJB12 ANXA2 ANXA2P2 MAT2A POLE GART PSMB7 SMC4 DDX1 DHX30 NOMO1 PARP1 URB1 FXR1 SNW1 NOMO2 MTHFD1 RBMX MTR HSPA9 NOMO3 | 2.41e-09 | 1257 | 121 | 21 | 37317656 |
| Pubmed | RBM10 GART RNF213 DDX1 DHX30 FXR1 SPATS2L LMNA MTHFD1 RBMX SUPT16H AKAP13 UHRF2 TOP2A TOP2B | 3.08e-09 | 601 | 121 | 15 | 33658012 | |
| Pubmed | Topoisomerase II regulates the maintenance of DNA methylation. | 4.84e-09 | 7 | 121 | 4 | 25451918 | |
| Pubmed | STRN3 MYH6 PDE6A MYH7B ANXA2 SMC4 HEATR1 ZFC3H1 DDX1 ABCB4 PARP1 FXR1 LMNA SACS RBMX SUPT16H ALDH2 CTTN CAMSAP2 HSPA9 TOP2A TOP2B | 5.01e-09 | 1442 | 121 | 22 | 35575683 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | MAT2A GART GATA2 SMC4 HEATR1 MCCC1 DDX1 DHX30 TGM2 PARP1 FXR1 SNW1 LMNA MTHFD1 RBMX FEN1 SUPT16H EIF3M HSPA9 TOP2A TOP2B | 5.53e-09 | 1318 | 121 | 21 | 30463901 |
| Pubmed | ANXA2 MAT2A RBM10 HEATR1 DDX1 DHX30 PARP1 SNW1 LMNA MTHFD1 RBMX FEN1 SUPT16H TOP2A TOP2B | 7.30e-09 | 641 | 121 | 15 | 36057605 | |
| Pubmed | 1.03e-08 | 234 | 121 | 10 | 36243803 | ||
| Pubmed | DHX58 GART PSMB7 SMC4 MCCC1 DDX1 DHX30 FXR1 SPATS2L MTHFD1 EIF3M HSPA9 TOP2A | 1.08e-08 | 469 | 121 | 13 | 37314180 | |
| Pubmed | DNAJB12 ANXA2 MAT2A GART SMC4 DDX1 DHX30 PARP1 NUDT11 FXR1 SNW1 LMNA MTHFD1 RBMX RCOR3 CTTN CAMSAP2 HSPA9 TOP2A FBXW11 | 1.20e-08 | 1247 | 121 | 20 | 27684187 | |
| Pubmed | TGM2 PARP1 FXR1 MTHFD1 RBMX FEN1 SUPT16H ALDH2 CTTN TOP2A TOP2B | 2.19e-08 | 327 | 121 | 11 | 31409639 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | ANXA2 PSMB7 IST1 HEATR1 ARHGAP1 PARP1 FXR1 SNW1 SACS FEN1 CTTN TOP2A CNN3 | 2.19e-08 | 498 | 121 | 13 | 36634849 |
| Pubmed | ANXA2 RBM10 PSME1 DDX1 DHX30 PARP1 FXR1 SPATS2L MTHFD1 RBMX CTTN EIF3M TOP2A TOP2B | 3.37e-08 | 615 | 121 | 14 | 31048545 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | DHX58 MAT2A SMC4 NOMO1 TWF1 PARP1 NOMO2 MTHFD1 SUPT16H HSPA9 NOMO3 | 3.66e-08 | 344 | 121 | 11 | 30333137 |
| Pubmed | ANXA2 MAT2A RBM10 POLE GART DDX1 DHX30 LENG8 PARP1 FXR1 MTHFD1 ALDH1L2 RBMX MTR HSPA9 | 3.70e-08 | 725 | 121 | 15 | 27025967 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | MYH7B RNF213 DDX1 DHX30 PARP1 SPATS2L LMNA MTHFD1 SUPT16H TOP2B | 3.73e-08 | 268 | 121 | 10 | 33024031 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | ANXA2 ANXA2P2 RBM10 NSD1 HEATR1 MCCC1 DDX1 LENG8 PARP1 SNW1 LMNA RBMX FEN1 SUPT16H CTTN TOP2A TOP2B | 3.74e-08 | 954 | 121 | 17 | 36373674 |
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 36011023 | ||
| Pubmed | 4.11e-08 | 3 | 121 | 3 | 22767497 | ||
| Pubmed | Silencing of nodal modulator 1 inhibits the differentiation of P19 cells into cardiomyocytes. | 4.11e-08 | 3 | 121 | 3 | 25576386 | |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | ANXA2 IST1 DDX1 HIRA DHX30 TWF1 TGM2 PARP1 FXR1 LMNA RBMX SUPT16H HSPA9 TOP2A | 4.19e-08 | 626 | 121 | 14 | 33644029 |
| Pubmed | MYH6 ANXA2 ANXA2P2 MAT2A GART RNF213 HEATR1 PSME1 DDX1 TGM2 SPATS2L LMNA MTHFD1 RBMX HSPA9 TOP2A | 4.19e-08 | 844 | 121 | 16 | 25963833 | |
| Pubmed | 4.23e-08 | 203 | 121 | 9 | 35012549 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | DNAJB12 STRN3 POLE PSMB7 RNF213 RTN4IP1 HEATR1 WARS2 GFM2 DHX30 ARHGAP1 PARP1 FXR1 SPATS2L ALDH1L2 RBMX SUPT16H MTR ALDH2 HSPA9 TOP2A | 4.87e-08 | 1496 | 121 | 21 | 32877691 |
| Pubmed | MAT2A RBM10 GART SMC4 PARP1 FXR1 SNW1 LMNA MTHFD1 RBMX HSPA9 TOP2A | 5.01e-08 | 441 | 121 | 12 | 31239290 | |
| Pubmed | GRIPAP1 ANXA2 PSMB7 SMC4 PSME1 DDX1 DHX30 TWF1 PARP1 FEN1 CTTN HSPA9 TOP2A | 5.39e-08 | 538 | 121 | 13 | 28524877 | |
| Pubmed | The RNA-binding protein HuR is a novel target of Pirh2 E3 ubiquitin ligase. | 8.42e-08 | 220 | 121 | 9 | 34091597 | |
| Pubmed | DNAJB12 ANXA2 MAT2A POLE PSMB7 SMC4 RNF213 PSME1 DDX1 PARP1 SNW1 SUPT16H CTTN UHRF2 EIF3M TOP2A TOP2B | 8.95e-08 | 1014 | 121 | 17 | 32416067 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | PRPSAP2 STRN3 ANXA2 MAT2A RBM10 GART PSMB7 SMC4 PSME1 DDX1 PARP1 FXR1 MTHFD1 FEN1 SUPT16H CTTN HSPA9 CNN3 | 9.92e-08 | 1149 | 121 | 18 | 35446349 |
| Pubmed | Liver and brain differential expression of one-carbon metabolism genes during ontogenesis. | 1.03e-07 | 33 | 121 | 5 | 34702858 | |
| Pubmed | ANXA2 MAT2A GART IST1 DDX1 DHX30 TWF1 LMNA MTHFD1 FEN1 SUPT16H CTTN EIF3M TOP2A TOP2B | 1.05e-07 | 786 | 121 | 15 | 29128334 | |
| Pubmed | DNAJB12 PRPSAP2 ANXA2 MAT2A GART SMC4 LAMC1 PIGG PSME1 DHX30 ARHGAP1 PARP1 SPATS2L NOMO2 MTHFD1 RBMX AKAP13 EIF3M HSPA9 | 1.19e-07 | 1297 | 121 | 19 | 33545068 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | SMC4 ZFC3H1 DDX1 DHX30 LENG8 PARP1 FXR1 SNW1 MTHFD1 FEN1 SUPT16H HSPA9 | 1.43e-07 | 486 | 121 | 12 | 30940648 |
| Pubmed | ANXA2 MAT2A GART SMC4 DDX1 DHX30 PARP1 SNW1 LMNA MTHFD1 RBMX FEN1 EIF3M HSPA9 FBXW11 | 1.53e-07 | 809 | 121 | 15 | 32129710 | |
| Pubmed | Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2. | 1.64e-07 | 4 | 121 | 3 | 39142074 | |
| Pubmed | Establishment of a conditional Nomo1 mouse model by CRISPR/Cas9 technology. | 1.64e-07 | 4 | 121 | 3 | 31833031 | |
| Pubmed | 1.64e-07 | 4 | 121 | 3 | 9267806 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | MAT2A RBM10 SMC4 DDX1 TWF1 FXR1 RBMX SUPT16H AKAP13 ALDH2 EIF3M HSPA9 TOP2A TOP2B | 1.67e-07 | 701 | 121 | 14 | 30196744 |
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 1.68e-07 | 315 | 121 | 10 | 26777405 | |
| Pubmed | ANXA2 GART IST1 HEATR1 DDX1 DHX30 TGM2 PARP1 LMNA MTHFD1 RBMX FEN1 HSPA9 TOP2A | 1.85e-07 | 707 | 121 | 14 | 19738201 | |
| Pubmed | MAT2A RBM10 GART SMC4 LAMC1 NOMO1 TGM2 LMNA NOMO2 MTHFD1 RBMX HSPA9 NOMO3 | 2.41e-07 | 613 | 121 | 13 | 22268729 | |
| Pubmed | Beta-catenin interacts with the FUS proto-oncogene product and regulates pre-mRNA splicing. | 2.46e-07 | 16 | 121 | 4 | 16230076 | |
| Pubmed | 2.49e-07 | 250 | 121 | 9 | 33536335 | ||
| Pubmed | 2.57e-07 | 251 | 121 | 9 | 31076518 | ||
| Pubmed | GART TBC1D2 NSD1 LAMC1 ARHGAP1 PARP1 LMNA SACS SUPT16H TOP2A | 2.72e-07 | 332 | 121 | 10 | 37433992 | |
| Pubmed | RNF213 HEATR1 DHX30 URB1 FXR1 SPATS2L SUPT16H TOP2A TOP2B FBXW11 | 2.72e-07 | 332 | 121 | 10 | 25693804 | |
| Pubmed | SPG7 ANXA2 RBM10 HEATR1 ZFC3H1 DHX30 LENG8 PARP1 SNW1 LMNA RBMX SUPT16H HSPA9 TOP2A | 2.77e-07 | 731 | 121 | 14 | 29298432 | |
| Pubmed | 3.09e-07 | 186 | 121 | 8 | 14744259 | ||
| Pubmed | 3.36e-07 | 188 | 121 | 8 | 29721183 | ||
| Pubmed | 3.39e-07 | 340 | 121 | 10 | 24332808 | ||
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 29339503 | ||
| Pubmed | 4.09e-07 | 5 | 121 | 3 | 15159385 | ||
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | MAT2A LAMC1 HIRA DHX30 LENG8 PARP1 URB1 SPATS2L FEN1 SUPT16H | 4.30e-07 | 349 | 121 | 10 | 25665578 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | RBM10 ZFC3H1 DHX30 LENG8 PARP1 FXR1 LMNA SUPT16H CTTN TOP2A TOP2B | 4.30e-07 | 440 | 121 | 11 | 34244565 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | ANXA2 MCCC1 HIRA PARP1 FXR1 SNW1 LMNA VWA5A CTTN TOP2A TOP2B | 4.70e-07 | 444 | 121 | 11 | 34795231 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 4.90e-07 | 271 | 121 | 9 | 32433965 | |
| Pubmed | 5.21e-07 | 136 | 121 | 7 | 21280222 | ||
| Pubmed | STRN3 MAT1A MAT2A GART GFM2 DDX1 PARP1 LMNA MTHFD1 CTTN HSPA9 | 5.49e-07 | 451 | 121 | 11 | 36168627 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ANXA2 RBM10 GATA2 NSD1 HEATR1 MCCC1 ZFC3H1 HIRA PARP1 URB1 SNW1 LMNA RBMX SUPT16H RCOR3 HSPA9 TOP2A TOP2B | 5.64e-07 | 1294 | 121 | 18 | 30804502 |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 6.01e-07 | 203 | 121 | 8 | 22083510 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | MAT2A RBM10 GART PSME1 DDX1 TWF1 FXR1 LMNA SUPT16H CTTN HSPA9 TOP2A CNN3 | 6.03e-07 | 665 | 121 | 13 | 30457570 |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | ANXA2 MAT2A RBM10 RNF213 DHX30 PARP1 MICU3 SPATS2L LMNA RBMX EIF3M HSPA9 | 6.20e-07 | 558 | 121 | 12 | 27591049 |
| Pubmed | MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | 7.89e-07 | 287 | 121 | 9 | 36180891 | |
| Pubmed | 7.91e-07 | 49 | 121 | 5 | 19161160 | ||
| Pubmed | 8.15e-07 | 6 | 121 | 3 | 19112534 | ||
| Pubmed | 8.15e-07 | 6 | 121 | 3 | 16731532 | ||
| Pubmed | PRPSAP2 ANXA2 MAT2A GART PSMB7 PSME1 DDX1 DHX30 PARP1 FXR1 LMNA MTHFD1 RBMX SUPT16H CTTN EIF3M HSPA9 CNN3 | 8.82e-07 | 1335 | 121 | 18 | 29229926 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | ANXA2P2 GART SMC4 PARP1 FXR1 LMNA MTHFD1 RBMX SUPT16H CTTN HSPA9 | 9.49e-07 | 477 | 121 | 11 | 31300519 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | RBM10 POLE SMC4 DDX1 TWF1 PARP1 SNW1 LMNA RBMX FEN1 CTTN TOP2A | 9.63e-07 | 582 | 121 | 12 | 20467437 |
| Pubmed | 9.98e-07 | 383 | 121 | 10 | 29331416 | ||
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | MAT2A GART IST1 DHX30 ARHGAP1 PARP1 SPATS2L SNW1 LMNA RBMX FEN1 ALDH2 HSPA9 | 1.14e-06 | 704 | 121 | 13 | 32994395 |
| Pubmed | 1.29e-06 | 54 | 121 | 5 | 35391932 | ||
| Pubmed | The cluster of BTN genes in the extended major histocompatibility complex. | 1.42e-06 | 7 | 121 | 3 | 11170752 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | ANXA2 RBM10 DDX1 DHX30 PARP1 SNW1 LMNA RBMX SUPT16H HSPA9 TOP2A TOP2B | 1.44e-06 | 605 | 121 | 12 | 28977666 |
| Pubmed | MAT2A RBM10 PSMB7 SMC4 PSME1 DDX1 LENG8 PARP1 SNW1 MTHFD1 RBMX FEN1 UHRF2 HSPA9 TOP2A TOP2B | 1.49e-06 | 1103 | 121 | 16 | 34189442 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | TAF1A MCCC1 ZFC3H1 HIRA ARHGAP1 URB1 FXR1 SPATS2L SNW1 AKAP13 CTTN CNN3 TOP2B | 1.55e-06 | 724 | 121 | 13 | 36232890 |
| Pubmed | 1.57e-06 | 312 | 121 | 9 | 37120454 | ||
| Pubmed | RBM10 SMC4 HEATR1 ZFC3H1 DDX1 DHX30 URB1 FXR1 SPATS2L SNW1 RBMX FEN1 TOP2A TOP2B | 1.58e-06 | 847 | 121 | 14 | 35850772 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | GRIPAP1 ANXA2 MAT2A PSMB7 SMC4 LAMC1 PSME1 DDX1 TWF1 PARP1 FEN1 CTTN EIF3M HSPA9 | 1.58e-06 | 847 | 121 | 14 | 35235311 |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | STRN3 GRIPAP1 ANXA2 IST1 PSME1 MCCC1 LENG8 ARHGAP1 NOMO2 CTTN CAMSAP2 HSPA9 TOP2A CNN3 | 1.72e-06 | 853 | 121 | 14 | 28718761 |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 1.75e-06 | 316 | 121 | 9 | 31665637 | |
| Pubmed | 1.86e-06 | 236 | 121 | 8 | 36339263 | ||
| Pubmed | ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ. | ANXA2P2 SMC4 HEATR1 MCCC1 DHX30 LENG8 PARP1 FXR1 SNW1 FEN1 SUPT16H FBXW11 | 1.98e-06 | 624 | 121 | 12 | 33729478 |
| Pubmed | Regulation of homocysteine homeostasis through the transcriptional coactivator PGC-1alpha. | 2.27e-06 | 8 | 121 | 3 | 19158324 | |
| Interaction | ILF3 interactions | ANXA2 TAF1A GART NSD1 PSME1 DDX1 DHX30 NOMO1 SGK2 PARP1 URB1 FXR1 SPATS2L LMNA MTHFD1 RBMX SUPT16H EIF3M HSPA9 TOP2A FBXW11 | 8.02e-08 | 896 | 121 | 21 | int:ILF3 |
| Interaction | ACE2 interactions | GRIPAP1 ANXA2 ANXA2P2 MAT2A RBM10 HEATR1 BTN3A2 BTN3A1 DDX1 DHX30 ARHGAP1 TGM2 PARP1 BTN3A3 SNW1 LMNA MTHFD1 RBMX FEN1 SUPT16H MMP14 TOP2A TOP2B | 1.54e-07 | 1106 | 121 | 23 | int:ACE2 |
| Interaction | IFI16 interactions | DHX58 MAT2A RBM10 GART RNF213 HEATR1 DDX1 DHX30 PARP1 URB1 FXR1 SPATS2L FEN1 SUPT16H HSPA9 TOP2A TOP2B FBXW11 | 2.62e-07 | 714 | 121 | 18 | int:IFI16 |
| Interaction | NAA40 interactions | STRN3 RBM10 GART IST1 HEATR1 MCCC1 DHX30 TWF1 LENG8 PARP1 SNW1 R3HCC1L MTHFD1 FEN1 SUPT16H CTTN CAMSAP2 HSPA9 TOP2A CNN3 TOP2B | 3.44e-07 | 978 | 121 | 21 | int:NAA40 |
| Interaction | CHMP4C interactions | ANXA2 ANXA2P2 MAT2A GART RNF213 DHX30 PARP1 FXR1 LMNA RBMX FEN1 SUPT16H CTTN EIF3M HSPA9 TOP2A TOP2B | 7.55e-07 | 687 | 121 | 17 | int:CHMP4C |
| Interaction | BIRC3 interactions | DYNC2H1 ANXA2 MAT2A GART SMC4 HEATR1 DDX1 DHX30 NOMO1 PARP1 URB1 FXR1 SNW1 LMNA MTHFD1 RBMX FEN1 SUPT16H ALDH2 CTTN EIF3M HSPA9 TOP2A TOP2B | 1.10e-06 | 1334 | 121 | 24 | int:BIRC3 |
| Interaction | PRC1 interactions | ANXA2 ANXA2P2 MAT2A RBM10 NTN3 ESRP1 SMC4 HEATR1 DDX1 DHX30 IQCA1L URB1 FXR1 SNW1 LMNA RBMX SUPT16H CTTN TOP2A TOP2B | 1.34e-06 | 973 | 121 | 20 | int:PRC1 |
| Interaction | ISG15 interactions | MYH7B ANXA2 PSMB7 IST1 RNF213 DDX1 DHX30 PARP1 SPATS2L LMNA MTHFD1 SUPT16H TOP2A TOP2B | 1.62e-06 | 494 | 121 | 14 | int:ISG15 |
| Interaction | DNAJC7 interactions | DNAJB12 DYNC2H1 ANXA2 POLE GART SPC25 PSME1 ARHGAP1 SNW1 SACS MTHFD1 MTR FBXW11 | 1.69e-06 | 425 | 121 | 13 | int:DNAJC7 |
| Interaction | SLX4 interactions | USP45 ANXA2 RBM10 GART MCCC1 ZFC3H1 REV3L DHX30 PARP1 SNW1 LMNA MTHFD1 RBMX SUPT16H HSPA9 | 1.76e-06 | 572 | 121 | 15 | int:SLX4 |
| Interaction | OBSL1 interactions | ANXA2 RBM10 GART PSMB7 HEATR1 DDX1 DHX30 PARP1 IQCA1L URB1 SPATS2L SNW1 LMNA RBMX SUPT16H CTTN HSPA9 TOP2A TOP2B | 1.78e-06 | 902 | 121 | 19 | int:OBSL1 |
| Interaction | SLFN11 interactions | DHX58 MYH7B ANXA2 RBM10 NSD1 RNF213 TEK PARP1 LMNA EIF3M HSPA9 TOP2A | 2.81e-06 | 376 | 121 | 12 | int:SLFN11 |
| Interaction | TNIP1 interactions | NDNF ANXA2 MAT1A ANXA2P2 MAT2A GART SMC4 HEATR1 DDX1 DHX30 TWF1 LENG8 PARP1 FXR1 LMNA MTHFD1 RBMX FEN1 SUPT16H CTTN HSPA9 TOP2A | 3.08e-06 | 1217 | 121 | 22 | int:TNIP1 |
| Interaction | NUPR1 interactions | RBM10 GART IST1 HEATR1 DDX1 DHX30 TWF1 TGM2 PARP1 FXR1 LMNA RBMX SUPT16H CTTN TOP2A TOP2B | 3.33e-06 | 683 | 121 | 16 | int:NUPR1 |
| Interaction | WDR76 interactions | ANXA2 RBM10 SMC4 LAMC1 PSME1 DDX1 PARP1 FXR1 LMNA FEN1 SUPT16H HSPA9 | 3.40e-06 | 383 | 121 | 12 | int:WDR76 |
| Interaction | SSRP1 interactions | PRPSAP2 RBM10 POLE ZFC3H1 TEK PARP1 SNW1 LMNA RBMX FEN1 SUPT16H UHRF2 PRDM16 EIF3M TOP2A TOP2B | 3.46e-06 | 685 | 121 | 16 | int:SSRP1 |
| Interaction | RBM39 interactions | ANXA2 MAT2A RBM10 HEATR1 DDX1 DHX30 PARP1 FXR1 SNW1 LMNA MTHFD1 RBMX FEN1 SUPT16H CTTN PRDM16 EIF3M HSPA9 TOP2A TOP2B | 3.79e-06 | 1042 | 121 | 20 | int:RBM39 |
| Interaction | KIF20A interactions | DYNC2H1 ANXA2 ANXA2P2 ESRP1 HEATR1 DDX1 DHX30 TWF1 PARP1 URB1 FXR1 LMNA FER1L4 RBMX SUPT16H ABCD1 CTTN TOP2A TOP2B FBXW11 | 4.38e-06 | 1052 | 121 | 20 | int:KIF20A |
| Interaction | EFTUD2 interactions | DNAJB12 PRPSAP2 ANXA2 MAT2A GART SPC25 SMC4 PSME1 WARS2 DDX1 DHX30 PARP1 FXR1 SNW1 LMNA MTHFD1 RBMX FEN1 SUPT16H AKAP13 EIF3M HSPA9 TOP2A TOP2B | 4.63e-06 | 1449 | 121 | 24 | int:EFTUD2 |
| Interaction | DNAJC3 interactions | 9.11e-06 | 226 | 121 | 9 | int:DNAJC3 | |
| Interaction | RANBP2 interactions | ESRP1 FXR1 SNW1 LMNA SUPT16H AKAP13 CTTN UHRF2 TOP2A TOP2B FBXW11 | 1.15e-05 | 361 | 121 | 11 | int:RANBP2 |
| Interaction | CUL7 interactions | ANXA2 RBM10 GART HEATR1 ZFC3H1 DDX1 PARP1 FXR1 SNW1 LMNA MTHFD1 RBMX SUPT16H EIF3M HSPA9 TOP2A TOP2B | 1.20e-05 | 845 | 121 | 17 | int:CUL7 |
| Interaction | SUMO2 interactions | SMC4 RNF213 ABCA8 DDX1 PARP1 SNW1 LMNA MTHFD1 SUPT16H RCOR3 UHRF2 HSPA9 TOP2A TOP2B | 1.26e-05 | 591 | 121 | 14 | int:SUMO2 |
| Interaction | CIT interactions | DYNC2H1 ANXA2 ANXA2P2 MAT2A RBM10 GART ESRP1 SMC4 RNF213 HEATR1 ADGRV1 DDX1 DHX30 URB1 FXR1 SNW1 LMNA RBMX SUPT16H UHRF2 EIF3M TOP2A TOP2B | 1.53e-05 | 1450 | 121 | 23 | int:CIT |
| Interaction | APOBEC3C interactions | 1.74e-05 | 187 | 121 | 8 | int:APOBEC3C | |
| Interaction | DHX40 interactions | 1.97e-05 | 249 | 121 | 9 | int:DHX40 | |
| Interaction | RAD18 interactions | RBM10 DDX1 DHX30 TWF1 LENG8 PARP1 SNW1 SUPT16H CTTN HSPA9 TOP2A TOP2B | 2.01e-05 | 457 | 121 | 12 | int:RAD18 |
| Interaction | MCM2 interactions | MYH6 ANXA2 ANXA2P2 MAT2A GART SMC4 RNF213 HEATR1 PSME1 DDX1 HIRA TGM2 PARP1 SPATS2L LMNA MTHFD1 RBMX SUPT16H HSPA9 | 2.35e-05 | 1081 | 121 | 19 | int:MCM2 |
| Interaction | PPP1CB interactions | GRIPAP1 ANXA2 GART RNF213 PSME1 TWF1 PARP1 SNW1 RBMX CTTN PRDM16 HSPA9 | 2.59e-05 | 469 | 121 | 12 | int:PPP1CB |
| Interaction | FBXO6 interactions | MAT2A RBM10 GART SMC4 LAMC1 NOMO1 TGM2 LMNA NOMO2 MTHFD1 RBMX ABCD1 MMP14 HSPA9 NOMO3 | 2.61e-05 | 717 | 121 | 15 | int:FBXO6 |
| Interaction | NR2C2 interactions | MAT2A GART GATA2 SMC4 HEATR1 MCCC1 DDX1 HIRA DHX30 TGM2 PARP1 FXR1 SNW1 LMNA MTHFD1 RBMX FEN1 SUPT16H EIF3M HSPA9 TOP2A TOP2B | 2.88e-05 | 1403 | 121 | 22 | int:NR2C2 |
| Interaction | SMC5 interactions | ANXA2 ANXA2P2 RBM10 NSD1 HEATR1 MCCC1 REV3L DDX1 LENG8 PARP1 SNW1 LMNA RBMX FEN1 SUPT16H CTTN TOP2A TOP2B | 2.89e-05 | 1000 | 121 | 18 | int:SMC5 |
| Interaction | BRD7 interactions | GATA2 SMC4 ZFC3H1 DDX1 DHX30 LENG8 PARP1 FXR1 SNW1 LMNA MTHFD1 FEN1 SUPT16H HSPA9 | 2.90e-05 | 637 | 121 | 14 | int:BRD7 |
| Interaction | BAZ1B interactions | 3.25e-05 | 204 | 121 | 8 | int:BAZ1B | |
| Interaction | LRRC31 interactions | 3.37e-05 | 205 | 121 | 8 | int:LRRC31 | |
| Interaction | FBXW7 interactions | ANXA2 RBM10 GART GATA2 RNF213 WARS2 DDX1 DHX30 FXR1 SPATS2L LMNA MTHFD1 RBMX FEN1 SUPT16H AKAP13 UHRF2 HSPA9 TOP2A TOP2B | 3.56e-05 | 1215 | 121 | 20 | int:FBXW7 |
| Interaction | C9orf72 interactions | DNAJB12 ANXA2 ANXA2P2 MAT2A POLE GART PSMB7 SMC4 DDX1 DHX30 NOMO1 PARP1 URB1 FXR1 SNW1 NOMO2 MTHFD1 RBMX MTR HSPA9 NOMO3 | 3.60e-05 | 1319 | 121 | 21 | int:C9orf72 |
| Interaction | HMGB1 interactions | ANXA2 TGM2 PARP1 SNW1 LMNA RBMX SUPT16H CTTN UHRF2 HSPA9 TOP2A TOP2B | 3.66e-05 | 486 | 121 | 12 | int:HMGB1 |
| Interaction | LOXL2 interactions | TGM2 PARP1 FXR1 MTHFD1 RBMX FEN1 SUPT16H ALDH2 CTTN TOP2A TOP2B | 3.72e-05 | 410 | 121 | 11 | int:LOXL2 |
| Interaction | ADARB1 interactions | RBM10 TAF1A DDX1 DHX30 URB1 SPATS2L SNW1 LMNA FEN1 HSPA9 TOP2A TOP2B | 3.89e-05 | 489 | 121 | 12 | int:ADARB1 |
| Interaction | NOP56 interactions | NSD1 HEATR1 ZFC3H1 DHX30 LENG8 PARP1 URB1 FXR1 LMNA SUPT16H PRDM16 TOP2A TOP2B | 3.89e-05 | 570 | 121 | 13 | int:NOP56 |
| Interaction | CCDC8 interactions | ANXA2 GART SMC4 LAMC1 HEATR1 DHX30 PARP1 FXR1 LMNA SACS MTHFD1 RBMX HSPA9 TOP2A | 3.99e-05 | 656 | 121 | 14 | int:CCDC8 |
| Interaction | PRMT1 interactions | PRPSAP2 ANXA2 RBM10 GART PSMB7 SMC4 DDX1 DHX30 TWF1 PARP1 FXR1 SNW1 LMNA MTHFD1 RBMX CTTN HSPA9 | 4.01e-05 | 929 | 121 | 17 | int:PRMT1 |
| Interaction | BMI1 interactions | ESRP1 GATA2 NSD1 HEATR1 LENG8 PARP1 FXR1 SPATS2L SNW1 LMNA SUPT16H UHRF2 EIF3M TOP2A | 4.19e-05 | 659 | 121 | 14 | int:BMI1 |
| Interaction | KIF23 interactions | NDNF ANXA2 ANXA2P2 GART SMC4 NSD1 HEATR1 ZFC3H1 DDX1 DHX30 PARP1 FXR1 LMNA RBMX SUPT16H ABCD1 TOP2A TOP2B | 4.31e-05 | 1031 | 121 | 18 | int:KIF23 |
| Interaction | ATXN1 interactions | MAT2A RBM10 GART ESRP1 GATA2 IST1 PSME1 DDX1 TWF1 FXR1 LMNA LOXL1 SUPT16H CTTN UHRF2 HSPA9 TOP2A CNN3 | 4.76e-05 | 1039 | 121 | 18 | int:ATXN1 |
| Interaction | CHD3 interactions | ANXA2 RBM10 PSME1 DDX1 DHX30 PARP1 SNW1 LMNA RBMX SUPT16H CTTN UHRF2 HSPA9 TOP2A TOP2B | 4.86e-05 | 757 | 121 | 15 | int:CHD3 |
| Interaction | CAPZB interactions | DNAJB12 PRPSAP2 BLNK RTN4IP1 PSME1 DDX1 HIRA DHX30 TWF1 PARP1 RBMX FEN1 CTTN EIF3M HSPA9 TOP2A CNN3 TOP2B | 5.39e-05 | 1049 | 121 | 18 | int:CAPZB |
| Interaction | EXOSC10 interactions | 6.11e-05 | 223 | 121 | 8 | int:EXOSC10 | |
| Interaction | PSPC1 interactions | ESRP1 DDX1 DHX30 PARP1 FXR1 SPATS2L MTHFD1 CTTN EIF3M CNN3 TOP2B NOMO3 | 6.40e-05 | 515 | 121 | 12 | int:PSPC1 |
| Interaction | ZC3H18 interactions | SPG7 ANXA2 RBM10 HEATR1 ZFC3H1 TEK DHX30 LENG8 PARP1 SNW1 LMNA RBMX SUPT16H HSPA9 TOP2A FBXW11 | 7.15e-05 | 877 | 121 | 16 | int:ZC3H18 |
| Interaction | TOP1 interactions | PRPSAP2 RBM10 POLE PARP1 SNW1 LMNA RBMX FEN1 SUPT16H ALDH2 CTTN PRDM16 TOP2A TOP2B | 7.53e-05 | 696 | 121 | 14 | int:TOP1 |
| Interaction | SCARNA22 interactions | 7.88e-05 | 118 | 121 | 6 | int:SCARNA22 | |
| Interaction | ZNF330 interactions | POLE NSD1 HEATR1 ZFC3H1 PARP1 URB1 RBMX FEN1 SUPT16H TOP2A TOP2B | 7.92e-05 | 446 | 121 | 11 | int:ZNF330 |
| Interaction | ECT2 interactions | ANXA2 ANXA2P2 HEATR1 PIGG DHX30 NOMO1 PARP1 LMNA RBMX SUPT16H GPSM2 ABCD1 CTTN EIF3M TOP2A TOP2B | 8.16e-05 | 887 | 121 | 16 | int:ECT2 |
| Interaction | PSMD5 interactions | 8.65e-05 | 120 | 121 | 6 | int:PSMD5 | |
| Interaction | BTF3 interactions | DNAJB12 ANXA2 IST1 DDX1 HIRA DHX30 TWF1 TGM2 PARP1 FXR1 LMNA RBMX SUPT16H HSPA9 TOP2A | 8.92e-05 | 799 | 121 | 15 | int:BTF3 |
| Interaction | RPA4 interactions | STRN3 ANXA2 RBM10 PARP1 FXR1 SNW1 FEN1 SUPT16H CTTN TOP2A CNN3 | 8.92e-05 | 452 | 121 | 11 | int:RPA4 |
| Interaction | C9orf78 interactions | DNAJB12 SMC4 MCCC1 LENG8 PARP1 FXR1 LMNA NOMO2 ALDH2 HSPA9 TOP2A CNN3 FBXW11 | 9.13e-05 | 620 | 121 | 13 | int:C9orf78 |
| Interaction | MTF1 interactions | 9.92e-05 | 123 | 121 | 6 | int:MTF1 | |
| Interaction | SNCA interactions | ANXA2 IST1 HEATR1 ARHGAP1 PARP1 FXR1 ARSA SNW1 SACS FEN1 CTTN HSPA9 TOP2A CNN3 | 1.02e-04 | 716 | 121 | 14 | int:SNCA |
| Interaction | SIRT6 interactions | ANXA2 RBM10 SMC4 ZFC3H1 DHX30 LENG8 PARP1 FXR1 LMNA SUPT16H CTTN TOP2A TOP2B | 1.04e-04 | 628 | 121 | 13 | int:SIRT6 |
| Interaction | BAP1 interactions | PRPSAP2 STRN3 ANXA2 MAT2A RBM10 GART PSMB7 GATA2 SMC4 PSME1 DDX1 PARP1 FXR1 MTHFD1 ALDH1L2 FEN1 SUPT16H CTTN HSPA9 CNN3 | 1.05e-04 | 1314 | 121 | 20 | int:BAP1 |
| Interaction | MEX3A interactions | GART TBC1D2 NSD1 LAMC1 ARHGAP1 PARP1 LMNA SACS SUPT16H TOP2A | 1.09e-04 | 384 | 121 | 10 | int:MEX3A |
| Interaction | LINC00240 interactions | 1.12e-04 | 16 | 121 | 3 | int:LINC00240 | |
| Interaction | CCNA2 interactions | 1.20e-04 | 183 | 121 | 7 | int:CCNA2 | |
| Interaction | EED interactions | GART SMC4 NSD1 LAMC1 HEATR1 DDX1 ARHGAP1 PARP1 URB1 FXR1 LMNA MTHFD1 RBMX SUPT16H CTTN UHRF2 EIF3M HSPA9 TOP2A CNN3 FBXW11 | 1.33e-04 | 1445 | 121 | 21 | int:EED |
| Interaction | MEN1 interactions | RBM10 ESRP1 SMC4 RNF213 HEATR1 ZFC3H1 DDX1 HIRA DHX30 LENG8 URB1 FXR1 SNW1 RBMX SUPT16H TOP2A TOP2B | 1.40e-04 | 1029 | 121 | 17 | int:MEN1 |
| Interaction | PAGE4 interactions | 1.47e-04 | 253 | 121 | 8 | int:PAGE4 | |
| Interaction | DDX23 interactions | RBM10 SMC4 HEATR1 URB1 SNW1 LMNA RBMX SUPT16H HSPA9 TOP2A TOP2B | 1.51e-04 | 480 | 121 | 11 | int:DDX23 |
| Interaction | RCHY1 interactions | 1.53e-04 | 325 | 121 | 9 | int:RCHY1 | |
| Interaction | WWP2 interactions | ANXA2 RBM10 IST1 PSME1 DDX1 DHX30 PARP1 FXR1 SPATS2L MTHFD1 RBMX CTTN EIF3M TOP2A TOP2B | 1.55e-04 | 840 | 121 | 15 | int:WWP2 |
| Interaction | ARHGAP24 interactions | STRN3 MAT1A MAT2A GART GFM2 DDX1 PARP1 LMNA MTHFD1 CTTN HSPA9 | 1.68e-04 | 486 | 121 | 11 | int:ARHGAP24 |
| Interaction | PSMD12 interactions | 1.76e-04 | 331 | 121 | 9 | int:PSMD12 | |
| Interaction | FUS interactions | ANXA2P2 MAT2A RBM10 PSMB7 DDX1 DHX30 PARP1 SNW1 LMNA MTHFD1 RBMX EIF3M HSPA9 FBXW11 | 1.82e-04 | 757 | 121 | 14 | int:FUS |
| Interaction | ATG16L1 interactions | GRIPAP1 MAT2A RBM10 SPC25 SMC4 DDX1 TWF1 PARP1 FXR1 RBMX SUPT16H MTR AKAP13 ALDH2 EIF3M HSPA9 TOP2A TOP2B | 1.94e-04 | 1161 | 121 | 18 | int:ATG16L1 |
| Interaction | HLTF interactions | 1.94e-04 | 139 | 121 | 6 | int:HLTF | |
| Interaction | NIPBL interactions | 2.01e-04 | 199 | 121 | 7 | int:NIPBL | |
| Interaction | POU5F1 interactions | PDE6A ANXA2 SMC4 LAMC1 HIRA PARP1 FEN1 SUPT16H HSPA9 TOP2A CNN3 TOP2B | 2.08e-04 | 584 | 121 | 12 | int:POU5F1 |
| Interaction | CYLD interactions | ANXA2 MAT2A RBM10 RNF213 NOX4 DHX30 PARP1 MICU3 SPATS2L LMNA MTHFD1 RBMX EIF3M HSPA9 CNN3 | 2.21e-04 | 868 | 121 | 15 | int:CYLD |
| Interaction | PINK1 interactions | ANXA2P2 GART SMC4 ARHGAP1 TGM2 PARP1 FXR1 LMNA MTHFD1 RBMX SUPT16H CTTN HSPA9 | 2.24e-04 | 679 | 121 | 13 | int:PINK1 |
| Interaction | ANOS1 interactions | 2.26e-04 | 143 | 121 | 6 | int:ANOS1 | |
| Interaction | PDCD6 interactions | 2.34e-04 | 204 | 121 | 7 | int:PDCD6 | |
| Interaction | NUDCD2 interactions | 2.42e-04 | 424 | 121 | 10 | int:NUDCD2 | |
| Interaction | SRRM1 interactions | 2.55e-04 | 348 | 121 | 9 | int:SRRM1 | |
| Interaction | UHRF1 interactions | 2.64e-04 | 208 | 121 | 7 | int:UHRF1 | |
| Interaction | HECTD1 interactions | ANXA2 POLE SMC4 HEATR1 ZFC3H1 DDX1 DHX30 PARP1 URB1 FXR1 SNW1 RBMX SUPT16H TOP2A TOP2B FBXW11 | 2.67e-04 | 984 | 121 | 16 | int:HECTD1 |
| Interaction | ASXL2 interactions | 2.71e-04 | 277 | 121 | 8 | int:ASXL2 | |
| Interaction | HNRNPUL1 interactions | 2.72e-04 | 351 | 121 | 9 | int:HNRNPUL1 | |
| Interaction | AR interactions | RBM10 BLNK NSD1 RNF213 DDX1 HIRA LENG8 PARP1 FXR1 SPATS2L SNW1 FEN1 SUPT16H RCOR3 HSPA9 TOP2B | 2.93e-04 | 992 | 121 | 16 | int:AR |
| Interaction | BRAF interactions | 2.96e-04 | 212 | 121 | 7 | int:BRAF | |
| Interaction | USP7 interactions | NTN3 GATA2 NSD1 DHX30 TGM2 PARP1 NUDT11 FXR1 LMNA LOXL1 RBMX SUPT16H ABCD1 CTTN UHRF2 PRDM16 HSPA9 TOP2A TOP2B | 3.04e-04 | 1313 | 121 | 19 | int:USP7 |
| Interaction | PARP1 interactions | PRPSAP2 MAT2A POLE SMC4 NSD1 HEATR1 PARP1 URB1 LMNA SACS RBMX FEN1 SUPT16H CTTN UHRF2 PRDM16 TOP2A CNN3 TOP2B | 3.13e-04 | 1316 | 121 | 19 | int:PARP1 |
| Interaction | IK interactions | 3.22e-04 | 215 | 121 | 7 | int:IK | |
| Interaction | H3C1 interactions | DYNC2H1 TAF1A PSMB7 NSD1 HIRA PARP1 SPATS2L SNW1 LMNA FEN1 SUPT16H UHRF2 PRDM16 TOP2A TOP2B | 3.28e-04 | 901 | 121 | 15 | int:H3C1 |
| Interaction | CPSF6 interactions | RBM10 TBC1D2 PSMB7 ZFC3H1 LENG8 PARP1 FXR1 SNW1 LMNA RBMX CTTN | 3.32e-04 | 526 | 121 | 11 | int:CPSF6 |
| Interaction | DLD interactions | MAT2A GART GATA2 IST1 DDX1 TWF1 MTHFD1 FEN1 SUPT16H EIF3M FBXW11 | 3.32e-04 | 526 | 121 | 11 | int:DLD |
| Interaction | ADAR interactions | 3.36e-04 | 286 | 121 | 8 | int:ADAR | |
| Interaction | HUWE1 interactions | ANXA2 MAT2A RBM10 PSMB7 HEATR1 PSME1 MCCC1 DDX1 PARP1 URB1 SNW1 NOMO2 MTHFD1 MTR EIF3M HSPA9 FBXW11 | 3.41e-04 | 1110 | 121 | 17 | int:HUWE1 |
| Interaction | STIP1 interactions | DNAJB12 MAT2A GART SMC4 HEATR1 DDX1 DHX30 NOMO1 PARP1 FXR1 LMNA MTHFD1 RBMX SUPT16H HSPA9 TOP2B | 3.42e-04 | 1006 | 121 | 16 | int:STIP1 |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 3.79e-05 | 15 | 81 | 3 | 458 | |
| GeneFamily | Aldehyde dehydrogenases | 7.97e-05 | 19 | 81 | 3 | 398 | |
| GeneFamily | Topoisomerases | 2.94e-04 | 6 | 81 | 2 | 1050 | |
| GeneFamily | ATP binding cassette subfamily B | 1.06e-03 | 11 | 81 | 2 | 806 | |
| GeneFamily | Endogenous ligands|Minor histocompatibility antigens | 1.55e-03 | 51 | 81 | 3 | 870 | |
| GeneFamily | ATP binding cassette subfamily A | 1.74e-03 | 14 | 81 | 2 | 805 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 2.00e-03 | 15 | 81 | 2 | 26 | |
| GeneFamily | Myosin heavy chains | 2.00e-03 | 15 | 81 | 2 | 1098 | |
| GeneFamily | DEAH-box helicases | 2.28e-03 | 16 | 81 | 2 | 500 | |
| GeneFamily | DNA polymerases | 4.72e-03 | 23 | 81 | 2 | 535 | |
| GeneFamily | Nudix hydrolase family | 5.13e-03 | 24 | 81 | 2 | 667 | |
| Coexpression | BLUM_RESPONSE_TO_SALIRASIB_DN | POLE SMC4 SLC39A8 PARP1 LMNA MTHFD1 FEN1 GPSM2 TOP2A CNN3 TOP2B | 5.50e-07 | 341 | 121 | 11 | M2879 |
| Coexpression | CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN | 1.89e-06 | 179 | 121 | 8 | M16932 | |
| Coexpression | GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN | 4.15e-06 | 199 | 121 | 8 | M6843 | |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | PRPSAP2 GART GATA2 SMC4 TEK MEIS1 SLC39A8 DDX1 HIRA NOMO1 TGM2 PARP1 SNW1 LMNA TIE1 MTHFD1 SUPT16H MTR EIF3M HSPA9 | 6.22e-06 | 1399 | 121 | 20 | M535 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | DYNC2H1 ANXA2 ANXA2P2 GART SMC4 GFM2 TWF1 TGM2 FXR1 ST3GAL6 FEN1 SUPT16H HSPA9 TOP2A | 6.28e-06 | 721 | 121 | 14 | M10237 |
| Coexpression | CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN | ANXA2 ANXA2P2 GART LAMC1 BTN3A2 BTN3A3 SPATS2L ST3GAL6 GPSM2 CAMTA1 MMP14 | 9.17e-06 | 457 | 121 | 11 | M14507 |
| Coexpression | KAUFFMANN_DNA_REPAIR_GENES | 1.20e-05 | 230 | 121 | 8 | M11563 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | ANXA2 ANXA2P2 SMC4 LAMC1 TGM2 SPATS2L LMNA SACS ALDH1L2 AKAP13 CAMSAP2 EIF3M CNN3 | 1.64e-05 | 681 | 121 | 13 | M39175 |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | USP45 MAT2A TAF1A GART SPC25 ESRP1 SMC4 RTN4IP1 GFM2 PARP1 SNW1 MTHFD1 VWA5A FEN1 GPSM2 EIF3M HSPA9 TOP2A | 2.64e-05 | 1290 | 121 | 18 | M80 |
| Coexpression | CHYLA_CBFA2T3_TARGETS_DN | 3.13e-05 | 263 | 121 | 8 | MM1295 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_B_CELL_AGEING | 3.48e-05 | 132 | 121 | 6 | MM3822 | |
| Coexpression | GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_UP | 3.61e-05 | 196 | 121 | 7 | M10014 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP | 3.73e-05 | 197 | 121 | 7 | M7543 | |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_DN | 3.98e-05 | 199 | 121 | 7 | M9422 | |
| Coexpression | GSE20727_CTRL_VS_ROS_INHIBITOR_TREATED_DC_DN | 3.98e-05 | 199 | 121 | 7 | M9242 | |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 4.11e-05 | 200 | 121 | 7 | M9439 | |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | 4.11e-05 | 200 | 121 | 7 | M291 | |
| Coexpression | GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_UP | 4.11e-05 | 200 | 121 | 7 | M4663 | |
| Coexpression | GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_DN | 4.11e-05 | 200 | 121 | 7 | M9576 | |
| Coexpression | GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN | 4.11e-05 | 200 | 121 | 7 | M9215 | |
| Coexpression | PILON_KLF1_TARGETS_UP | MYH7B C1GALT1 ABCA8 SLC39A8 SPATS2L FCN1 SUPT16H CTTN HSPA9 TOP2A KNG1 | 4.32e-05 | 541 | 121 | 11 | MM1061 |
| Coexpression | DESCARTES_ORGANOGENESIS_DEFINITIVE_ERYTHROID_LINEAGE | 6.07e-05 | 46 | 121 | 4 | MM3654 | |
| Coexpression | BROWNE_HCMV_INFECTION_14HR_DN | 6.23e-05 | 290 | 121 | 8 | M13251 | |
| Coexpression | LEE_BMP2_TARGETS_DN | USP45 MAT2A GART HEATR1 NOMO1 PARP1 URB1 SACS NOMO2 MTHFD1 FEN1 HSPA9 CNN3 NOMO3 | 9.29e-05 | 922 | 121 | 14 | MM1068 |
| Coexpression | HUANG_GATA2_TARGETS_DN | 9.30e-05 | 98 | 121 | 5 | MM942 | |
| Coexpression | SCHLOSSER_SERUM_RESPONSE_DN | DNAJB12 PRPSAP2 MYH6 BLNK LAMC1 REV3L SLC39A8 TWF1 TGM2 EIF3M TOP2B FBXW11 | 1.06e-04 | 705 | 121 | 12 | M1410 |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN | 1.16e-04 | 164 | 121 | 6 | M13108 | |
| Coexpression | PILON_KLF1_TARGETS_UP | MYH7B C1GALT1 ABCA8 SLC39A8 SPATS2L SUPT16H CTTN HSPA9 TOP2A KNG1 | 1.17e-04 | 503 | 121 | 10 | M2226 |
| Coexpression | WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP | 1.39e-04 | 22 | 121 | 3 | M2082 | |
| Coexpression | IBRAHIM_NRF1_UP | 1.49e-04 | 420 | 121 | 9 | M42509 | |
| Coexpression | VANTVEER_BREAST_CANCER_METASTASIS_DN | 1.54e-04 | 109 | 121 | 5 | M9826 | |
| Coexpression | FISCHER_DREAM_TARGETS | MAT2A POLE TAF1A GART SPC25 SMC4 HEATR1 MTHFD1 FEN1 SUPT16H GPSM2 RFT1 HSPA9 TOP2A | 1.56e-04 | 969 | 121 | 14 | M149 |
| Coexpression | GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_UP | 1.61e-04 | 174 | 121 | 6 | M6296 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | STRN3 SPC25 LAMC1 REV3L HIRA FXR1 SNW1 SACS MTR AKAP13 CAMSAP2 TOP2A FBXW11 | 1.67e-04 | 856 | 121 | 13 | M4500 |
| Coexpression | THUM_SYSTOLIC_HEART_FAILURE_UP | 1.77e-04 | 430 | 121 | 9 | M3654 | |
| Coexpression | GCNP_SHH_UP_LATE.V1_UP | 1.99e-04 | 181 | 121 | 6 | M2641 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | DYNC2H1 GART SMC4 HEATR1 GFM2 TWF1 FXR1 FEN1 SUPT16H GPSM2 HSPA9 | 2.01e-04 | 644 | 121 | 11 | M10501 |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | PRPSAP2 MAT2A POLE SPC25 SMC4 HIRA PARP1 RBMX FEN1 EIF3M HSPA9 TOP2A | 2.14e-04 | 761 | 121 | 12 | M11961 |
| Coexpression | OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP | 2.22e-04 | 349 | 121 | 8 | M283 | |
| Coexpression | TRAVAGLINI_LUNG_PROLIFERATING_BASAL_CELL | SPC25 ESRP1 PSMB7 SMC4 PSME1 PARP1 MTHFD1 FEN1 SUPT16H GPSM2 EIF3M HSPA9 TOP2A | 2.47e-04 | 891 | 121 | 13 | M41654 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | MAT2A TAF1A GART ALDH8A1 SMC4 RNF213 LAMC1 HEATR1 FXR1 SACS RBMX FEN1 MTR GPSM2 CAMTA1 EIF3M TOP2A | 2.56e-04 | 1407 | 121 | 17 | M14427 |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN | 2.89e-04 | 194 | 121 | 6 | M7306 | |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | LAMC1 REV3L ARHGAP1 BTN3A3 URB1 SNW1 SACS SUPT16H MTR AKAP13 CTTN CAMSAP2 | 3.01e-04 | 790 | 121 | 12 | M12490 |
| Coexpression | CHICAS_RB1_TARGETS_CONFLUENT | ANXA2 WNT2 ANXA2P2 ARHGAP1 TGM2 SPATS2L LMNA LOXL1 RBMX CNN3 | 3.06e-04 | 567 | 121 | 10 | M2129 |
| Coexpression | PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6 | 3.21e-04 | 29 | 121 | 3 | M2412 | |
| Coexpression | XIE_LT_HSC_S1PR3_OE_UP | 3.21e-04 | 29 | 121 | 3 | M41754 | |
| Coexpression | GSE39022_LN_VS_SPLEEN_DC_DN | 3.22e-04 | 198 | 121 | 6 | M9018 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_BCELL_DN | 3.22e-04 | 198 | 121 | 6 | M5411 | |
| Coexpression | GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_UP | 3.31e-04 | 199 | 121 | 6 | M9306 | |
| Coexpression | GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN | 3.31e-04 | 199 | 121 | 6 | M9595 | |
| Coexpression | GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_DN | 3.31e-04 | 199 | 121 | 6 | M6205 | |
| Coexpression | GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_DN | 3.31e-04 | 199 | 121 | 6 | M7667 | |
| Coexpression | GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_UP | 3.31e-04 | 199 | 121 | 6 | M10018 | |
| Coexpression | GSE17721_0.5H_VS_8H_POLYIC_BMDC_DN | 3.31e-04 | 199 | 121 | 6 | M4094 | |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN | 3.40e-04 | 200 | 121 | 6 | M4593 | |
| Coexpression | GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_UP | 3.40e-04 | 200 | 121 | 6 | M9598 | |
| Coexpression | GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_DN | 3.40e-04 | 200 | 121 | 6 | M3488 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_UP | 3.40e-04 | 200 | 121 | 6 | M7431 | |
| Coexpression | GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_DN | 3.40e-04 | 200 | 121 | 6 | M6404 | |
| Coexpression | GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_DN | 3.40e-04 | 200 | 121 | 6 | M5300 | |
| Coexpression | GSE22886_DC_VS_MONOCYTE_DN | 3.40e-04 | 200 | 121 | 6 | M4472 | |
| Coexpression | GSE20715_0H_VS_48H_OZONE_LUNG_DN | 3.40e-04 | 200 | 121 | 6 | M4369 | |
| Coexpression | BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP | 3.78e-04 | 204 | 121 | 6 | M34006 | |
| Coexpression | BENPORATH_ES_1 | 3.86e-04 | 379 | 121 | 8 | M1871 | |
| Coexpression | DANG_BOUND_BY_MYC | MAT2A NTN3 PSMB7 LAMC1 MEIS1 SLC39A8 DDX1 PARP1 FXR1 LMNA MTHFD1 SUPT16H ALDH2 HSPA9 | 3.93e-04 | 1061 | 121 | 14 | M15774 |
| Coexpression | MANALO_HYPOXIA_DN | 4.24e-04 | 292 | 121 | 7 | M18562 | |
| Coexpression | YAMASHITA_LIVER_CANCER_STEM_CELL_DN | 4.29e-04 | 76 | 121 | 4 | M9206 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 4.32e-04 | 32 | 121 | 3 | M5903 | |
| Coexpression | OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_0DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_UP | 4.37e-04 | 7 | 121 | 2 | M41171 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | 4.59e-04 | 597 | 121 | 10 | MM1309 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN | 4.68e-04 | 491 | 121 | 9 | MM455 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_UP | 4.75e-04 | 213 | 121 | 6 | M14601 | |
| Coexpression | ALCALAY_AML_BY_NPM1_LOCALIZATION_UP | 4.90e-04 | 140 | 121 | 5 | M9377 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12 | 5.21e-04 | 80 | 121 | 4 | M19891 | |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN | 5.39e-04 | 143 | 121 | 5 | M9149 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12 | 5.46e-04 | 81 | 121 | 4 | MM875 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | 5.56e-04 | 612 | 121 | 10 | M4772 | |
| Coexpression | ZHANG_UTERUS_C0_MATURATIONAL_UP | 5.81e-04 | 8 | 121 | 2 | MM16603 | |
| Coexpression | ATM_DN.V1_DN | 5.93e-04 | 146 | 121 | 5 | M2691 | |
| Coexpression | STEIN_ESR1_TARGETS | 5.99e-04 | 83 | 121 | 4 | M9678 | |
| Coexpression | BORCZUK_MALIGNANT_MESOTHELIOMA_UP | 6.05e-04 | 310 | 121 | 7 | M10236 | |
| Coexpression | IGLESIAS_E2F_TARGETS_UP | 6.30e-04 | 148 | 121 | 5 | MM1010 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | NDNF MYH7B POLE SPC25 SMC4 NSD1 NOX4 C1GALT1 HEATR1 MCCC1 SLC39A8 DHX30 FXR1 REEP6 FEN1 SUPT16H UHRF2 EIF3M TOP2A TOP2B | 2.30e-05 | 1241 | 121 | 20 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | NDNF MYH7B POLE SPC25 SMC4 NSD1 NOX4 C1GALT1 HEATR1 MCCC1 TEK SLC39A8 DHX30 NUDT11 FXR1 REEP6 FEN1 SUPT16H UHRF2 EIF3M TOP2A TOP2B | 2.60e-05 | 1468 | 121 | 22 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2 | POLE GATA2 TEK MEIS1 NOMO1 TGM2 TIE1 ALDH2 CTTN PRDM16 TOP2A | 3.02e-05 | 422 | 121 | 11 | GSM399442_500 |
| CoexpressionAtlas | B cells, MLP.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R- CD, Fetal Liver, avg-3 | POLE SPC25 GATA2 TEK MEIS1 TIE1 MTHFD1 FEN1 ALDH2 TOP2A CNN3 | 3.22e-05 | 425 | 121 | 11 | GSM791131_500 |
| CoexpressionAtlas | B cells, proB.FrBC.BM, CD19+ IgM- CD43+ AA4.1+ CD45R+, Bone marrow, avg-2 | 1.01e-04 | 401 | 121 | 10 | GSM399450_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_500 | BLNK LAMC1 REV3L WARS2 SGK2 ST3GAL6 AKAP13 CAMSAP2 PRDM16 KNG1 | 1.03e-04 | 402 | 121 | 10 | gudmap_developingKidney_e15.5_anlage of loop of Henle_500 |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1 | 1.19e-04 | 409 | 121 | 10 | GSM476663_500 | |
| CoexpressionAtlas | Stem Cells, SC.LTSL.BM, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-2 | 1.33e-04 | 86 | 121 | 5 | GSM399442_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_1000 | CHDH ESRP1 BLNK GATA2 LAMC1 REV3L SLC39A8 ST3GAL6 RBMX NUDT10 CAMSAP2 PRDM16 KNG1 TOP2B | 1.33e-04 | 774 | 121 | 14 | gudmap_developingKidney_e15.5_cortic collect duct_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | DYNC2H1 POLE PIGG ADGRV1 REV3L WARS2 DHX30 ST3GAL6 FEN1 AKAP13 CAMTA1 UHRF2 CAMSAP2 TOP2B | 1.43e-04 | 779 | 121 | 14 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_top-relative-expression-ranked_1000 | BLNK NSD1 LAMC1 REV3L WARS2 MEIS1 SGK2 ST3GAL6 RBMX AKAP13 CAMSAP2 PRDM16 KNG1 TOP2B | 1.76e-04 | 795 | 121 | 14 | gudmap_developingKidney_e15.5_anlage of loop of Henle_1000 |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | 1.83e-04 | 92 | 121 | 5 | GSM791126_100 | |
| ToppCell | Immune_cells-large_pre-B.|Immune_cells / Lineage and Cell class | 1.80e-10 | 198 | 121 | 10 | bc9ceefadb153907d2854d1f736d17349003cb31 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.18e-08 | 198 | 121 | 8 | 844f534551483c89ef789d1cfeb4680e54f794b2 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.47e-08 | 199 | 121 | 8 | 5478b78349b5d8d57f30bb650dcbd5fdb84283d6 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.47e-08 | 199 | 121 | 8 | fe3b7d540a644dfc6beea171c809b4d1ba4e188f | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.47e-08 | 199 | 121 | 8 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.47e-08 | 199 | 121 | 8 | cdee798e3586e4e7a15de598239090a85752ea1e | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.76e-07 | 182 | 121 | 7 | ea4f6c8f600ffe9f8e0609637b3371a5ac48ca03 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.01e-07 | 183 | 121 | 7 | 28e1fc6498aaf8f42c4d6d4fa54ffff4c546d0d1 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.01e-07 | 183 | 121 | 7 | 667d9107af17fd076ceff6b2cbcb78f892fd62d2 | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.11e-07 | 187 | 121 | 7 | 936aaca144b79a809617cbe3058bf434a4b3d46a | |
| ToppCell | COVID_non-vent-Myeloid-Dendritic-cDC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 8.11e-07 | 187 | 121 | 7 | 55fe4e8b4f301876716c1af15c34d42164f2358e | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-07 | 188 | 121 | 7 | 4dc89c7843ebd078e3414e835c56f11fa27f0c5f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-07 | 188 | 121 | 7 | d577b3c2a844e3062c7ca9e9ebc1722d0ac95caa | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.40e-07 | 188 | 121 | 7 | 1e788b60dd643bf220d8dfafa82d85fd083cbc71 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.71e-07 | 189 | 121 | 7 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | droplet-Spleen-nan-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.02e-07 | 190 | 121 | 7 | a273fc119baebc11020009c923beafeebb6428c9 | |
| ToppCell | (02)_Cycling_Basal_(regeneration)|World / shred by cell type and Timepoint | 9.02e-07 | 190 | 121 | 7 | 53f017a11ca5ebe9025558e12cedc409cab2e5aa | |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | 1.11e-06 | 196 | 121 | 7 | af206bb5bbb8b604a6212acd79878bcc3d326cec | |
| ToppCell | B_cell_maturation-CD34+_pro-B|World / Lineage and Cell class | 1.11e-06 | 196 | 121 | 7 | 4cb046883e56524963f6469ddb3b82c3c9853379 | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 1.11e-06 | 196 | 121 | 7 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.19e-06 | 198 | 121 | 7 | 8aa4149d2c1cec73cfd654db093252ec8ec5ef68 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.23e-06 | 199 | 121 | 7 | 3d876f172487425b37b2f658dae59e0f293ee76e | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.23e-06 | 199 | 121 | 7 | 8daf945fc93169b0a4fa3ef9f4a87eedd52e314a | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B-B_lineage|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.23e-06 | 199 | 121 | 7 | ea75804c34989c99aab542e6d72617ed144819b6 | |
| ToppCell | 10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.23e-06 | 199 | 121 | 7 | 8e7f9312dec1e3a92b6a0ccc7baa2d46e89c11f3 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_B|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.23e-06 | 199 | 121 | 7 | 713dfd8552635645db5e0b5721c64e5c9b4aa06c | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.23e-06 | 199 | 121 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Megakaryocytic-erythropoietic-Erythro-cells-Basophilic_Erythroblast|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 1.23e-06 | 199 | 121 | 7 | 6f159c1215439ec22374903124085746fa8da333 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.27e-06 | 200 | 121 | 7 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.27e-06 | 200 | 121 | 7 | 19a4213f180ac2d29625d140b602a93a74ab3fdd | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.27e-06 | 200 | 121 | 7 | c28d4ca51d2e2a3a22784ee251975f16a55b0297 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.27e-06 | 200 | 121 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.27e-06 | 200 | 121 | 7 | 364f09eb9ae4913f5c80a29e943e1c0b2ffd5f93 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-intermediate_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.27e-06 | 200 | 121 | 7 | 6461d25fd8fb52921b188f083fbe808535d3130b | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_B-B_lineage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.27e-06 | 200 | 121 | 7 | 0fd9a8730b7dc461ddf4586899d363541e72d8ba | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Pericentral)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-06 | 160 | 121 | 6 | c42bcc6c7d113f0db43febb088b75ca4ac7cb7a3 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 8.16e-06 | 174 | 121 | 6 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.43e-06 | 175 | 121 | 6 | 6b4e841bde6cfa4956e1a0231672cea20f11210c | |
| ToppCell | COVID-19-kidney-PCT-S3-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.71e-06 | 176 | 121 | 6 | b6497324e3e52f514ce556a3fa0c3011c45dcc7b | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.00e-06 | 177 | 121 | 6 | a68c3688f12aee22f3cb4049c4bccacbacb0fae6 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.90e-06 | 180 | 121 | 6 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.90e-06 | 180 | 121 | 6 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-05 | 182 | 121 | 6 | e6968e0bd9cef92052d04ac54e2dd746b37623f6 | |
| ToppCell | Immune_cells-large_pre-B.|World / Lineage and Cell class | 1.09e-05 | 183 | 121 | 6 | 81b5ed6ed661d2d6a9b807fefd2f0d59bd4ea77e | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 186 | 121 | 6 | ac6e32cf07f0f013101ca7aedae0c562857f182b | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 186 | 121 | 6 | 7cdcf507a9a1349ed2cf62b79116367c3fc732dd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-05 | 187 | 121 | 6 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-05 | 187 | 121 | 6 | dceca7ae3dae96078cccc17a0d8a61b06fa6dffb | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-05 | 188 | 121 | 6 | f1a9d8ea174a4bef0fae8188e3bd96b7ac1a39bb | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.31e-05 | 189 | 121 | 6 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.31e-05 | 189 | 121 | 6 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.31e-05 | 189 | 121 | 6 | e32172ad09e93f6ac6ea2b92145b2b73003f7970 | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.31e-05 | 189 | 121 | 6 | d049f33115610bda4489968759f754730698b9cd | |
| ToppCell | (02)_Cycling_Basal_(regeneration)-(1)_24hpi|(02)_Cycling_Basal_(regeneration) / shred by cell type and Timepoint | 1.31e-05 | 189 | 121 | 6 | 311f3aed469be3c8ff913dcc5a2442daa8446d55 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.35e-05 | 190 | 121 | 6 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.39e-05 | 191 | 121 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_A_+_HSC|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 192 | 121 | 6 | 959c28d28397bc0b9d3970d1fe3293d2750e63d4 | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-05 | 192 | 121 | 6 | a94f47a664a3c9d1b0250269674453309ab4bf95 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.43e-05 | 192 | 121 | 6 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-05 | 192 | 121 | 6 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-05 | 193 | 121 | 6 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.51e-05 | 194 | 121 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.51e-05 | 194 | 121 | 6 | c197e4acbff42a9f0410b6801c2bfcf6160aefc1 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-05 | 194 | 121 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-05 | 194 | 121 | 6 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.51e-05 | 194 | 121 | 6 | af4bbb2deb5a3913eb58990690fc3c62fbc3708c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-05 | 194 | 121 | 6 | 4c1d13d8cb6fb424655c67755ee6dbaf59d6b418 | |
| ToppCell | BLOOD--(1)_T_cell-(1)_Activated_T_cells|(1)_T_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.51e-05 | 194 | 121 | 6 | 6a0cbb9d5c5c4effb02dff654c6c3b184026875c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.56e-05 | 195 | 121 | 6 | 4658fb197657d7692ee344ae76b11b0210c418ba | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.56e-05 | 195 | 121 | 6 | f54bc4454270ff06e85596f98199372b50d0179f | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.56e-05 | 195 | 121 | 6 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.56e-05 | 195 | 121 | 6 | bfaceb0601cf3855f38d6e1f482f01ad03ef11fe | |
| ToppCell | IIF-Myeloid-cDC|IIF / Disease, Lineage and Cell Type | 1.56e-05 | 195 | 121 | 6 | 81225852a5827e973cb3b1da5c41e93d5407ecb6 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.56e-05 | 195 | 121 | 6 | eca24039bde02f4677f1f89a373f501c649ec2a5 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 196 | 121 | 6 | 31b91cba24f20a336d340c747eaafde7bbe2a428 | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.61e-05 | 196 | 121 | 6 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.61e-05 | 196 | 121 | 6 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | Epithelial-Epithelial-A_(AT1)|Epithelial / shred on cell class and cell subclass (v4) | 1.61e-05 | 196 | 121 | 6 | 41b21a18125cc95bc8adde3369e4abd029cf137d | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.61e-05 | 196 | 121 | 6 | ef1482f83872af72a55b6c5b5a1491e6f7f44dd7 | |
| ToppCell | Control-Stromal-Fibroblast|Control / Disease state, Lineage and Cell class | 1.61e-05 | 196 | 121 | 6 | 7ca94477498a84cafcdd9933ee92a6cbde76c70e | |
| ToppCell | myeloid-pro-pDC|myeloid / Lineage and Cell class | 1.61e-05 | 196 | 121 | 6 | 70daf4fabb68aecc5cc9f03d6f6495dd29b74a16 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.65e-05 | 197 | 121 | 6 | 9162ede5572326c00ede0769fe7f4e0dd14d2340 | |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 1.65e-05 | 197 | 121 | 6 | d51f484b4e01ac64233950d0b97fa88825ea1dbb | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-B-Large_pre-B|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.65e-05 | 197 | 121 | 6 | 7e0834b3947031bf244a10624dcf3f2095c79368 | |
| ToppCell | PBMC-Mild-Myeloid-cDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.65e-05 | 197 | 121 | 6 | 021c9c48375259b808e1f36a029c4fe6971c00eb | |
| ToppCell | PBMC-Mild-Myeloid-cDC|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.65e-05 | 197 | 121 | 6 | 18df0e447bcea2a405a357563f87bacc57466227 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.65e-05 | 197 | 121 | 6 | 81718164c9802ee20c860ffbda7e62d5e9a76f16 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.65e-05 | 197 | 121 | 6 | 0460b6907743a354792b5bc40bff01aac7c41684 | |
| ToppCell | COVID-19_Mild-Myeloid-cDC|COVID-19_Mild / Disease group, lineage and cell class | 1.65e-05 | 197 | 121 | 6 | 2901904b8a791fac2668fd737eff7e7144378db4 | |
| ToppCell | mild-Others-CD34+_GATA2+_cells|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.65e-05 | 197 | 121 | 6 | a375edbc885ae069f9abcd8d5886fdaa8913f83d | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|Fibroblasts / Location, Cell class and cell subclass | 1.65e-05 | 197 | 121 | 6 | 44f37a98f07c3e46a7e8fd3b64c2b2b44d5bbe40 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.65e-05 | 197 | 121 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.65e-05 | 197 | 121 | 6 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.70e-05 | 198 | 121 | 6 | 148f5fee19ea8dff7f2de4ca69c3b03e5221985d | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 1.70e-05 | 198 | 121 | 6 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-05 | 198 | 121 | 6 | a1ccbf0e653b2dd665c2254920eb9b37243cc0bd | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.70e-05 | 198 | 121 | 6 | e36303628af3139310c1d7a84d2919b7319bbda4 | |
| ToppCell | Control-Stromal|Control / Disease state, Lineage and Cell class | 1.70e-05 | 198 | 121 | 6 | ae726b6b7f0a4107899be4d32ac256ffa0bd8d59 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_capillary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-05 | 198 | 121 | 6 | 1d30a1f73b6d6d838f49751402a29c5ef54aa81f | |
| ToppCell | 5'-Adult-LymphNode-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.70e-05 | 198 | 121 | 6 | d7e15e61b6018e4c36461c9471ee29601929925c | |
| Computational | Neighborhood of PCNA | 5.77e-05 | 83 | 88 | 6 | MORF_PCNA | |
| Computational | Neighborhood of MSH2 | 7.39e-05 | 28 | 88 | 4 | GNF2_MSH2 | |
| Computational | Response to DNA damage. | 1.42e-04 | 187 | 88 | 8 | MODULE_244 | |
| Drug | Vitamin K 3 | MAT2A GART ESRP1 SMC4 LAMC1 NOX4 HEATR1 ADGRV1 MCCC1 DDX1 SGK2 PARP1 ST3GAL6 REEP6 MTHFD1 RBMX FEN1 RCOR3 ALDH2 TOP2A KNG1 TOP2B | 5.51e-07 | 1249 | 120 | 22 | ctd:D024483 |
| Drug | vinylidene chloride | NDNF ANXA2 POLE GATA2 ALDH8A1 SMC4 NSD1 LAMC1 UROC1 TEK SLC39A8 SGK2 TGM2 NUDT11 SPATS2L ARSA LMNA SACS REEP6 MTHFD1 ALDH1L2 FEN1 PRDM16 TOP2A | 6.47e-07 | 1475 | 120 | 24 | ctd:C029297 |
| Drug | 2,3-bis(3'-hydroxybenzyl)butyrolactone | STRN3 ANXA2 ANXA2P2 RBM10 POLE SPC25 BLNK GATA2 SMC4 SLC39A8 PARP1 MTHFD1 FEN1 SUPT16H GPSM2 RCOR3 AKAP13 CTTN TOP2A | 6.61e-07 | 961 | 120 | 19 | ctd:C029497 |
| Drug | N5,N10-methylene tetrahydrofolic acid | 2.83e-06 | 75 | 120 | 6 | CID000000884 | |
| Drug | AC1L9GCG | 4.31e-06 | 46 | 120 | 5 | CID000444451 | |
| Drug | Vancomycin | ANXA2 BLNK ALDH8A1 SMC4 NOX4 RTN4IP1 PSME1 MCCC1 SLC39A8 SGK2 TGM2 PARP1 LMNA MTHFD1 LOXL1 ABCB11 ALDH2 | 5.48e-06 | 906 | 120 | 17 | ctd:D014640 |
| Drug | 5-methyltetrahydrofolate | 5.89e-06 | 85 | 120 | 6 | CID000000146 | |
| Drug | 10-CHO-THF | 6.56e-06 | 50 | 120 | 5 | CID000000010 | |
| Drug | AC1L8RPE | 7.97e-06 | 52 | 120 | 5 | CID000407007 | |
| Drug | KCC 009 | 1.17e-05 | 9 | 120 | 3 | ctd:C510621 | |
| Drug | adenine | MAT1A MAT2A POLE GART NSD1 NOX4 REV3L WARS2 NUDT11 MTHFD1 FEN1 NUDT10 | 1.65e-05 | 510 | 120 | 12 | CID000000190 |
| Drug | adenosine 5'-tetraphosphate | 2.75e-05 | 2 | 120 | 2 | ctd:C017991 | |
| Drug | Dexrazoxane | 2.75e-05 | 2 | 120 | 2 | DB00380 | |
| Drug | tasosartan | 2.75e-05 | 2 | 120 | 2 | ctd:C086167 | |
| Drug | F14512 | 2.75e-05 | 2 | 120 | 2 | ctd:C534191 | |
| Drug | Daunorubicin | 2.75e-05 | 2 | 120 | 2 | DB00694 | |
| Drug | diadenosine 5',5''''-P1,P6-hexaphosphate | 2.75e-05 | 2 | 120 | 2 | ctd:C070070 | |
| Drug | benziodarone | 2.75e-05 | 2 | 120 | 2 | ctd:C058702 | |
| Drug | tipranavir | 2.75e-05 | 2 | 120 | 2 | ctd:C107201 | |
| Drug | adenosine 5'-pentaphosphate | 2.75e-05 | 2 | 120 | 2 | ctd:C048567 | |
| Drug | 2-amino-4-methylthio-3-butenoic acid | 2.75e-05 | 2 | 120 | 2 | ctd:C083253 | |
| Drug | methylmalonic acid | 2.99e-05 | 68 | 120 | 5 | CID000000487 | |
| Drug | pyrophosphate | PRPSAP2 MYH6 MYH7B MAT1A MAT2A POLE REV3L WARS2 NUDT11 FEN1 NUDT10 MTR ALDH2 | 4.22e-05 | 654 | 120 | 13 | CID000001023 |
| Drug | a-factor | 4.22e-05 | 73 | 120 | 5 | CID000119102 | |
| Drug | Aapfcmk | 6.20e-05 | 15 | 120 | 3 | CID005487540 | |
| Drug | 3-isoreserpine | 6.78e-05 | 190 | 120 | 7 | CID000005052 | |
| Drug | 4-epidoxorubicin | MYH6 MYH7B POLE GART PSMB7 REV3L ABCB4 TGM2 PARP1 NOMO2 SUPT16H ABCB11 HSPA9 TOP2B | 7.09e-05 | 788 | 120 | 14 | CID000001690 |
| Drug | Naloxone hydrochloride [357-08-4]; Down 200; 11uM; PC3; HG-U133A | 7.73e-05 | 194 | 120 | 7 | 1924_DN | |
| Drug | L-2-amino-4-methylthio-cis-but-3-enoic acid | 8.24e-05 | 3 | 120 | 2 | CID006439623 | |
| Drug | benzylphosphate | 8.24e-05 | 3 | 120 | 2 | CID000074359 | |
| Drug | Naftifine hydrochloride [65473-14-5]; Up 200; 12.4uM; HL60; HT_HG-U133A | 8.51e-05 | 197 | 120 | 7 | 2974_UP | |
| Drug | Aztreonam [78110-38-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 8.51e-05 | 197 | 120 | 7 | 2282_DN | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Up 200; 11uM; HL60; HT_HG-U133A | 8.78e-05 | 198 | 120 | 7 | 2549_UP | |
| Drug | 16 alpha-ethyl-21-hydroxy-19-nor-4-pregnene-3,20-dione | 9.25e-05 | 45 | 120 | 4 | ctd:C020175 | |
| Disease | Colorectal Carcinoma | RBM10 POLE LAMC1 ABCA8 ABCB4 TGM2 PARP1 ABCA6 SACS FCN1 FEN1 ABCB11 ALDH2 UHRF2 CAMSAP2 | 1.79e-07 | 702 | 120 | 15 | C0009402 |
| Disease | Vasodilators used in cardiac diseases use measurement | 1.10e-05 | 34 | 120 | 4 | EFO_0009926 | |
| Disease | B cell deficiency (implicated_via_orthology) | 1.64e-05 | 2 | 120 | 2 | DOID:2115 (implicated_via_orthology) | |
| Disease | Colorectal Neoplasms | 1.85e-05 | 277 | 120 | 8 | C0009404 | |
| Disease | Left ventricular noncompaction | 2.31e-05 | 14 | 120 | 3 | C1960469 | |
| Disease | coronary artery disease | DHX58 DYNC2H1 MAT2A RNF213 LAMC1 C1GALT1 TEK ABCA8 HIRA PARP1 R3HCC1L LOXL1 RBMX AKAP13 ALDH2 PRDM16 | 2.78e-05 | 1194 | 120 | 16 | EFO_0001645 |
| Disease | Progressive intrahepatic cholestasis (disorder) | 4.91e-05 | 3 | 120 | 2 | C0268312 | |
| Disease | Progressive familial intrahepatic cholestasis type 3 | 4.91e-05 | 3 | 120 | 2 | cv:C1865643 | |
| Disease | Cholestasis, benign recurrent intrahepatic 1 | 4.91e-05 | 3 | 120 | 2 | C4551899 | |
| Disease | Neural tube defects, folate-sensitive | 9.79e-05 | 4 | 120 | 2 | cv:C1866558 | |
| Disease | intrahepatic cholestasis (is_implicated_in) | 9.79e-05 | 4 | 120 | 2 | DOID:1852 (is_implicated_in) | |
| Disease | left ventricular noncompaction (implicated_via_orthology) | 9.79e-05 | 4 | 120 | 2 | DOID:0060480 (implicated_via_orthology) | |
| Disease | Cholestasis, progressive familial intrahepatic 1 | 9.79e-05 | 4 | 120 | 2 | C4551898 | |
| Disease | Neural tube defect, folate-sensitive | 9.79e-05 | 4 | 120 | 2 | C1866558 | |
| Disease | NEURAL TUBE DEFECTS, FOLATE-SENSITIVE | 9.79e-05 | 4 | 120 | 2 | 601634 | |
| Disease | angina pectoris | 1.63e-04 | 125 | 120 | 5 | EFO_0003913 | |
| Disease | melanoma | 1.69e-04 | 126 | 120 | 5 | EFO_0000756 | |
| Disease | spina bifida (is_implicated_in) | 2.43e-04 | 6 | 120 | 2 | DOID:0080016 (is_implicated_in) | |
| Disease | Esophageal Neoplasms | 2.94e-04 | 78 | 120 | 4 | C0014859 | |
| Disease | Malignant neoplasm of esophagus | 2.94e-04 | 78 | 120 | 4 | C0546837 | |
| Disease | urate measurement | POLE ESRP1 NSD1 ADGRV1 BTN3A2 SLC39A8 DDX1 SPATS2L LMNA AKAP13 ALDH2 RFT1 | 2.96e-04 | 895 | 120 | 12 | EFO_0004531 |
| Disease | aspartate aminotransferase measurement | MYH7B SPC25 NSD1 RNF213 NOX4 C1GALT1 SLC39A8 ABCB4 ARSA ABCB11 AKAP13 ALDH2 | 3.24e-04 | 904 | 120 | 12 | EFO_0004736 |
| Disease | frozen shoulder | 3.40e-04 | 7 | 120 | 2 | EFO_1000941 | |
| Disease | cholesteryl ester 16:0 measurement | 4.25e-04 | 36 | 120 | 3 | EFO_0010341 | |
| Disease | Cholestasis of pregnancy | 4.52e-04 | 8 | 120 | 2 | C0268318 | |
| Disease | arteriosclerosis (biomarker_via_orthology) | 4.52e-04 | 8 | 120 | 2 | DOID:2349 (biomarker_via_orthology) | |
| Disease | Industrial Dermatosis | 4.52e-04 | 8 | 120 | 2 | C0086457 | |
| Disease | Dermatitis, Occupational | 4.52e-04 | 8 | 120 | 2 | C0028796 | |
| Disease | descending aortic diameter | 4.66e-04 | 88 | 120 | 4 | EFO_0021788 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 5.80e-04 | 9 | 120 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | cholestasis (implicated_via_orthology) | 5.80e-04 | 9 | 120 | 2 | DOID:13580 (implicated_via_orthology) | |
| Disease | upper face morphology measurement | 6.73e-04 | 97 | 120 | 4 | EFO_0010949 | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 7.23e-04 | 10 | 120 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 7.23e-04 | 10 | 120 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 7.23e-04 | 10 | 120 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 7.23e-04 | 10 | 120 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 7.23e-04 | 10 | 120 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 7.23e-04 | 10 | 120 | 2 | cv:C5675009 | |
| Disease | inclusion body myositis (implicated_via_orthology) | 7.23e-04 | 10 | 120 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | vascular endothelial growth factor receptor 3 measurement | 7.23e-04 | 10 | 120 | 2 | EFO_0008315 | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 7.23e-04 | 10 | 120 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 7.23e-04 | 10 | 120 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Familial dilated cardiomyopathy | 7.69e-04 | 44 | 120 | 3 | C0340427 | |
| Disease | cancer (implicated_via_orthology) | 8.17e-04 | 268 | 120 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 9.93e-04 | 48 | 120 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 1.05e-03 | 12 | 120 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.05e-03 | 12 | 120 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 1.05e-03 | 12 | 120 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | fasting blood glucose measurement | 1.16e-03 | 287 | 120 | 6 | EFO_0004465 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 1.24e-03 | 13 | 120 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Mammary Carcinoma, Human | 1.41e-03 | 525 | 120 | 8 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.41e-03 | 525 | 120 | 8 | C1257931 | |
| Disease | Mammary Neoplasms | 1.44e-03 | 527 | 120 | 8 | C1458155 | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 1.45e-03 | 14 | 120 | 2 | DOID:4450 (biomarker_via_orthology) | |
| Disease | BMI-adjusted waist circumference, physical activity measurement | 1.63e-03 | 123 | 120 | 4 | EFO_0007789, EFO_0008002 | |
| Disease | Breast Carcinoma | 1.64e-03 | 538 | 120 | 8 | C0678222 | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.66e-03 | 15 | 120 | 2 | DOID:0050646 (implicated_via_orthology) | |
| Disease | lipid metabolism disorder (implicated_via_orthology) | 1.66e-03 | 15 | 120 | 2 | DOID:3146 (implicated_via_orthology) | |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 1.90e-03 | 60 | 120 | 3 | EFO_0020690 | |
| Disease | Necrotizing Enterocolitis | 2.14e-03 | 17 | 120 | 2 | C0520459 | |
| Disease | Animal Mammary Neoplasms | 2.74e-03 | 142 | 120 | 4 | C0024667 | |
| Disease | Mammary Carcinoma, Animal | 2.74e-03 | 142 | 120 | 4 | C1257925 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 3.18e-03 | 148 | 120 | 4 | C0279702 | |
| Disease | lung cancer (is_implicated_in) | 3.45e-03 | 74 | 120 | 3 | DOID:1324 (is_implicated_in) | |
| Disease | uric acid measurement | 3.54e-03 | 610 | 120 | 8 | EFO_0004761 | |
| Disease | Down syndrome (is_marker_for) | 3.59e-03 | 22 | 120 | 2 | DOID:14250 (is_marker_for) | |
| Disease | hair colour measurement | 3.72e-03 | 615 | 120 | 8 | EFO_0007822 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EKVRSYVKRALAEGA | 336 | Q9H2A2 | |
| EAARLVQTAFRKYKG | 1526 | Q9Y6Y1 | |
| GDFYEKALVELKVAA | 131 | O00478 | |
| GDFYEKALVELKVAA | 131 | O00481 | |
| RVAATYEAGALSLKK | 406 | Q96Q42 | |
| KTIKEVAEAYRSVGA | 86 | Q3SY69 | |
| YASLADVDKAVAAAK | 476 | Q3SY69 | |
| EVYAAVKGLRKADAR | 1376 | Q8N139 | |
| VKDVIGAVDSKVASY | 2181 | Q12802 | |
| VQYATKDGKATARER | 1036 | Q8WXG9 | |
| LKAYAKAGVVADEVI | 271 | O95342 | |
| RAAETADGKYAQKLF | 21 | Q9UGM1 | |
| RDLYDAGVKRKGTDV | 196 | P07355 | |
| GYGSKKIDAERQAAA | 101 | Q7L2E3 | |
| QDLYDAGVKRKGTDV | 196 | A6NMY6 | |
| KEIDAFVRAKADSAY | 496 | Q8NE62 | |
| EVYKATGEDFLKIAG | 296 | Q6NXG1 | |
| ASINTAYERKDGKFV | 366 | P50281 | |
| AAVREVYEEAGVKGK | 61 | Q8NFP7 | |
| ATRAAKAKARAYAEF | 711 | Q7Z5L2 | |
| GVRKYGKDFQAIADV | 301 | Q9P2K3 | |
| ESATADAGYAILEKK | 686 | P98175 | |
| DGTYKKALQEAAARF | 1831 | Q96L73 | |
| KAYALAGVSFEIKAE | 871 | P69849 | |
| EKALEAVFGKYGRIV | 21 | P38159 | |
| YIFFAKVLERGKDAT | 301 | Q96AA3 | |
| RNAVLEADFAKRGYK | 21 | Q99436 | |
| AEKTLGDFAAEYAKS | 106 | P09874 | |
| SVNDALKRDKDAIYG | 66 | O00470 | |
| GYSESDAEAVKKAAL | 356 | P33897 | |
| VDSKAYADARVLVAK | 481 | O60320 | |
| KAYALAGVSFEIKAE | 871 | Q5JPE7 | |
| GIKAAYEAELGDARK | 76 | P02545 | |
| IAKEFGDKAAERRAY | 231 | P81274 | |
| TFRIYGESADAVKKA | 261 | P51114 | |
| AFSGKDYTKVDRSAA | 281 | P31153 | |
| GYLVDKFADRERKVA | 726 | Q96PV6 | |
| AELRAYLKSKGAEIS | 16 | Q7L2H7 | |
| EYRAGAVKVGSKVFL | 1386 | A9Z1Z3 | |
| YDLLDAATGKKVAEG | 461 | Q08397 | |
| VDEFDGKVTYGQKRA | 681 | Q92499 | |
| TASVVAAYKGKRRSD | 176 | A7E2Y1 | |
| EIVGVATFYNRKDGK | 396 | P16499 | |
| FDNKRIVSGAYDGKI | 451 | Q9UKB1 | |
| KAYALAGVSFEIKAE | 871 | Q15155 | |
| GDAYAARDKSKLIQL | 56 | Q9UII6 | |
| AYVGTFARTKEEAKQ | 326 | Q8TB73 | |
| AFSGKDYTKVDRSAA | 281 | Q00266 | |
| AAVREVYEEAGVKGK | 61 | Q96G61 | |
| DEFKRAVYVATGLKF | 456 | Q86XE3 | |
| DEVRGVFAVRTGKYK | 381 | P15289 | |
| RVAKAEEGASYRKVN | 1371 | Q07864 | |
| AALAYGLDKSEDKVI | 226 | P38646 | |
| DEIAKYNRGKTVGVF | 531 | Q9NPH5 | |
| FSDKELAAYAKAGAV | 241 | P21439 | |
| KKDYAVQVAVGARGE | 461 | O00634 | |
| ADEAEKYKLVLGAFV | 226 | O00602 | |
| EAKTGVEKRYLAAGA | 26 | Q96HR9 | |
| SAARGEDKDGVKYQV | 201 | P23769 | |
| AEVILYSEGFKDAKV | 1826 | Q8NCM8 | |
| NDIKSYFGRKVAIDA | 21 | P39748 | |
| RKKNGEEYFGSVAEI | 411 | Q8WV28 | |
| GVSRGASDEDLKKAY | 116 | Q9NXW2 | |
| TVAAVALKKIGYDAS | 136 | Q5UAW9 | |
| ALKKIGYDASDVSVG | 141 | Q5UAW9 | |
| YVAKRHLETVDGAKV | 36 | Q96C10 | |
| GDFYEKALVELKVAA | 131 | P78410 | |
| KLGEAAVRAAKAVNY | 301 | Q96RQ3 | |
| DGTVKKVFYREGAQA | 691 | Q96RQ3 | |
| ARKEIADYLAAGKDE | 36 | P53990 | |
| AAETLKERGAYKIFV | 281 | O60256 | |
| EAKRAGDKAVEIYAS | 1256 | P11047 | |
| VVAGKKYFIDFVARE | 311 | P01042 | |
| AGYVLSKEALKRFVD | 211 | Q9NS00 | |
| KTVLAAAYGEKDAIL | 1426 | Q9H583 | |
| GKYIASQADDRSLKV | 186 | P54198 | |
| VAALQERYGKEAGKF | 151 | Q4V328 | |
| ERYGKEAGKFSAVSE | 156 | Q4V328 | |
| TKLALIAADYAVRGK | 4481 | Q9NZJ4 | |
| IAADYAVRGKSDKDV | 4486 | Q9NZJ4 | |
| KYFSERGDAVTKAAK | 176 | Q06323 | |
| KVVGDVAYDEAKERA | 251 | P11586 | |
| VELGADGKVVSYAKF | 231 | Q9BTV7 | |
| AAGAEDEKVYTDRAK | 816 | Q08AD1 | |
| KLGADDVIDYKSGSV | 246 | Q8WWV3 | |
| RYKLAVADAVIEKFA | 301 | Q9UGM6 | |
| KAYIASAGADALAKV | 781 | Q13033 | |
| GASFKYAVESIREKL | 201 | Q969S9 | |
| LAKRKSDGAFYAVKV | 51 | Q9HBY8 | |
| GRARKEVKYFAESDE | 1601 | Q02880 | |
| FVSERKYDEELGKAA | 321 | Q9NUQ6 | |
| YVETVAIGGKRRKDF | 36 | Q15573 | |
| RKSESVALKDYIGDF | 501 | A6NCM1 | |
| DSIKAIASIAEKYFG | 691 | Q9HAZ2 | |
| IFNDKTVGGEARKVY | 996 | Q99707 | |
| AGDDKYGRKIIVFSA | 76 | Q07960 | |
| AADFRKIASLYGSDK | 66 | Q9Y274 | |
| KLKEFGTARVAEGIY | 81 | O15266 | |
| EYAVERVLAGTAKKS | 546 | Q9UQ90 | |
| AEVVAAYRGKKRSEA | 136 | P13533 | |
| KEGFDKIDISAVVAY | 156 | Q9Y5B9 | |
| AFVSAAKKLPREDVY | 51 | O60287 | |
| GLRDTYKDSIKAFAE | 31 | Q9HBM1 | |
| EVYAAVKGLRKGDAE | 1381 | O94911 | |
| TYGLAAAVFTKDLDK | 441 | P05091 | |
| GVKYAEKQTRRFDEG | 141 | Q15417 | |
| VRAIKEGDLSTKYDA | 376 | P21980 | |
| KVYKASDSAEAIEAF | 676 | Q96PU4 | |
| GDEYKALRDAVAKAV | 4331 | Q63HN8 | |
| IDYGIKFARAFVDAK | 161 | P09544 | |
| SFAEKKVEGVYTNAR | 656 | Q70EL2 | |
| AFEEAYARADKKAPR | 336 | Q7RTX1 | |
| DRKTGAVYVAEIGAK | 316 | Q5JS37 | |
| KASIQDFIFAKEYRG | 2901 | O60673 | |
| KYGVQADRVDKSAVG | 161 | Q14247 | |
| ADVEKKGAGRTEFRY | 416 | Q96N76 | |
| ADFGLSRGEEVYVKK | 996 | P35590 | |
| FKTEYDAVAEKAGKV | 866 | Q9NTJ3 | |
| VYSFEALVDGKKIVA | 61 | O00534 | |
| DSEGKIKYDAIARQG | 91 | Q13573 | |
| ADFGLSRGQEVYVKK | 981 | Q02763 | |
| GLAAIKFEGAIYRKD | 406 | P22102 | |
| RRAYDIAGSTKDVKV | 241 | P11388 | |
| KVDSYVEKAVAVFGG | 191 | Q9C0K1 | |
| AKAAGKRIVFYGDET | 151 | Q5H8A4 | |
| LKYGEELARAKAVAS | 911 | O60293 | |
| EGTKVVFRYALAIFK | 816 | Q9BYX2 | |
| EDVKEIFARARNGKY | 11 | Q12792 |